References

Ref. 1. Siegel RL, et al. (2026) CA Cancer J Clin, 76: e70043. Available from: https://doi.org/10.3322/caac.70043

Ref. 2. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2026 Apr 22. [cited 2026 May 11]. Data source(s): SEER Incidence Data, November 2025 Submission (1975-2023), SEER 21 registries. Available from: https://seer.cancer.gov/statistics-network/explorer/

Ref. 3. Hewitt M, et al. (1999) J Natl Cancer Inst, 91: 1480. Available from: https://doi.org/10.1093/jnci/91.17.1480

Ref. 4. Wagle NS, et al. (2025) CA Cancer J Clin, 75: 308. Available from: https://doi.org/10.3322/caac.70011

Ref. 5. National Cancer Institute. Cancer Disparities. Accessed: March 31, 2026. Available from: https://www.cancer.gov/about-cancer/understanding/disparities

Ref. 6. US Department of Commerce, Economics and Statistics Administration. Demographic turning points for the United States: Population projections for 2020 to 2060. Accessed: March 31, 2026. Available from: https://www.census.gov/library/publications/2020/demo/p25-1144.html

Ref. 7. SEER*Stat Database: Mortality – All COD, Aggregated With State, Total U.S. (1990-2023) , National Cancer Institute, DCCPS, Surveillance Research Program, released February 2025.

Ref. 8. Centers for Disease Control and Prevention. Cancer Statistics At a Glance. Accessed: March 17, 2026. Available from: https://gis.cdc.gov/Cancer/USCS/#/

Ref. 9. Espey DK, et al. (2014) Am J Public Health, 104 Suppl 3: S286. Available from: https://doi.org/10.2105/AJPH.2013.301716

Ref. 10. Jim MA, et al. (2014) Am J Public Health, 104 Suppl 3: S295. Available from: https://doi.org/10.2105/AJPH.2014.301933

Ref. 11. Arias E, et al. (2021) Natl Vital Stat Rep, 70: 1. Available from: http://dx.crossref.org/10.15620/cdc/157499

Ref. 12. Llaneza AJ, et al. (2024) Health Equity, 8: 376. Available from: https://doi.org/10.1089/heq.2023.0252

Ref. 13. Satpathy Y, et al. (2023) JAMA Netw Open, 6: e2350237. Available from: https://doi.org/10.1001/jamanetworkopen.2023.50237

Ref. 14. SEER*Stat Database: NAACCR Incidence Data – CiNA Research Data, 1995-2022, Public Use (19 Age Groups) (which includes data from CDC’s National Program of Cancer Registries (NPCR), CCR’s Provincial and Territorial Registries, and the NCI’s Surveillance, Epidemiology and End Results (SEER) Registries), submitted December 2024

Ref. 15. SEER*Stat Database: Incidence – SEER Research Plus Limited-Field Data, 21 Registries, November 2025 submission (2000-2023).

Ref. 16. KFF. Key Data on Health and Health Care for American Indian or Alaska Native People. Accessed: March 31, 2026. Available from: https://www.kff.org/racial-equity-and-health-policy/key-data-on-health-and-health-care-for-american-indian-or-alaska-native-people/

Ref. 17. Islami F, et al. (2026) CA Cancer J Clin, 76: e70045. Available from: https://doi.org/10.3322/caac.70045

Ref. 18. Haverkamp D, et al. (2023) Int J Circumpolar Health, 82: 2184749. Available from: https://doi.org/10.1080/22423982.2023.2184749

Ref. 19. Siegel RL, et al. (2026) CA Cancer J Clin, 76: e70067. Available from: https://doi.org/10.3322/caac.70067

Ref. 20. Kratzer TB, et al. (2023) CA Cancer J Clin, 73: 120. Available from: https://doi.org/10.3322/caac.21757

Ref. 21. Thakkar Z, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 1134. Available from: https://doi.org/10.1158/1055-9965.EPI-24-1688

Ref. 22. Shing JZ, et al. (2023) JNCI Cancer Spectr, 7. Available from: https://doi.org/10.1093/jncics/pkad012

Ref. 23. Sanchez-Covarrubias AP, et al. (2025) Lancet Reg Health Am, 52: 101292. Available from: https://doi.org/10.1016/j.lana.2025.101292

Ref. 24. Parada H, Jr., et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 491. Available from: https://doi.org/10.1158/1055-9965.EPI-24-1325

Ref. 25. Yazzie D, et al. (2025) Cancer, 131: e70202. Available from: https://doi.org/10.1002/cncr.70202

Ref. 26. Pew Research Center. Asian Americans are the fastest-growing racial or ethnic group in the U.S. Accessed: March 17, 2024. Available from: https://www.pewresearch.org/short-reads/2021/04/09/asian-americans-are-the-fastest-growing-racial-or-ethnic-group-in-the-u-s/

Ref. 27. Centers for Disease Control and Prevention. Underlying Cause of Death, 2018-2021, Single Race. Accessed: March 17, 2024. Available from: https://wonder.cdc.gov/ucd-icd10-expanded.html

Ref. 28. Taparra K, et al. (2024) JAMA Netw Open, 7: e2430975. Available from: https://doi.org/10.1001/jamanetworkopen.2024.30975

Ref. 29. Lee RJ, et al. (2021) The Oncologist, 26: 453. Available from: https://doi.org/10.1002/onco.13748

Ref. 30. Park JY, et al. (2025) Nat Med, 31: 3020. Available from: https://doi.org/10.1038/s41591-025-03793-6

Ref. 31. Giaquinto AN, et al. (2024) CA Cancer J Clin, 74: 477. Available from: https://doi.org/10.3322/caac.21863

Ref. 32. SEER*Stat Database: NCCR Survival Data (ages 0-39), 23 States and Seattle, Dec 2024 NAACCR Sub (1997-2022) (which includes data from CDC’s National Program of Cancer Registries (NPCR), CCR’s Provincial and Territorial Registries, and the NCI’s Surveillance, Epidemiology and End Results (SEER) Registries). Registries included: CO, CA, CT, GA, HI, ID, IL, IA, KY, LA, MA, MI, MN, MO, NJ, NY, NM, NY, OR, PA, TN, TX, WI, UT, and Seattle.

Ref. 33. Morey BN, et al. (2019) Prev Chronic Dis, 16: E20. Available from: https://doi.org/10.5888/pcd16.180221

Ref. 34. University of California San Francisco. Crane Study. Accessed: March 31, 2026. Available from: https://cranestudy.ucsf.edu/

Ref. 35. Pinheiro PS, et al. (2025) JAMA Netw Open, 8: e252208. Available from: https://doi.org/10.1001/jamanetworkopen.2025.2208

Ref. 36. Park A, et al. (2025) Cancer Med, 14: e71259. Available from: https://doi.org/10.1002/cam4.71259

Ref. 37. Wang CC, et al. (2026) Sci Rep, 16. Available from: https://doi.org/10.1038/s41598-025-33389-6

Ref. 38. DeRouen MC, et al. (2022) J Natl Cancer Inst, 114: 78. Available from: https://doi.org/10.1093/jnci/djab143

Ref. 39. Sakoda LC, et al. (2023) Chest, 164: 785. Available from: https://doi.org/10.1016/j.chest.2023.03.016

Ref. 40. Blechter B, et al. (2024) Br J Cancer, 130: 1286. Available from: https://doi.org/10.1038/s41416-024-02592-z

Ref. 41. Murphy C, et al. (2025) JAMA, 334: 1836. Available from: https://doi.org/10.1001/jama.2025.17695

Ref. 42. Gomez SL, et al. (2025) J Natl Cancer Inst, 117: 1104. Available from: https://doi.org/10.1093/jnci/djae299

Ref. 43. University of California San Francisco. FANS Study. Accessed: March 31, 2026. Available from: https://fansstudy.ucsf.edu/home

Ref. 44. International Association for the Study of Lung Cancer. FANSS Study Demonstrates Feasibility of U.S.-Based Lung Cancer Screening in Asian Female Nonsmokers. Accessed: March 31, 2026. Available from: https://www.iaslc.org/iaslc-news/press-release/fanss-study-demonstrates-feasibility-us-based-lung-cancer-screening-asian

Ref. 45. National Cancer Institute. Sherlock-Lung: Tracing Lung Cancer Mutational Processes in Never Smokers. Accessed: March 31, 2026. Available from: https://dceg.cancer.gov/research/cancer-types/lung/sherlock-lung-study

Ref. 46. ClinicalTrials.gov. Lung Cancer Screening in Population Who Had Never Smoked. Accessed: March 31, 2026. Available from: https://clinicaltrials.gov/study/NCT07383454

Ref. 47. Saka AH, et al. (2025) CA Cancer J Clin, 75: 111. Available from: https://doi.org/10.3322/caac.21874

Ref. 48. Tsai MH, et al. (2025) Cancer Control, 32: 10732748251357469. Available from: https://doi.org/10.1177/10732748251357469

Ref. 49. Abubakar AK, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 1341. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0113

Ref. 50. Yu M, et al. (2024) J Natl Cancer Inst, 116: 1145. Available from: https://doi.org/10.1093/jnci/djae052

Ref. 51. Fernandez J, et al. (2023) Journal of Economic Perspectives, 37: 145. Available from: https://doi.org/10.1257/jep.37.1.145

Ref. 52. Trejo BG, et al. (2024) BMJ Public Health, 2: e001191. Available from: https://doi.org/10.1136/bmjph-2024-001191

Ref. 53. Gupta A, et al. (2024) Cancer Epidemiol, 92: 102632. Available from: https://doi.org/10.1016/j.canep.2024.102632

Ref. 54. American Cancer Society. Cancer Facts and Figures for Hispanic/Latino People 2024-2026. Accessed: April 4, 2026. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-hispanics-and-latinos/2024/2024-2026-cancer-facts-and-figures-for-hispanics-and-latinos.pdf

Ref. 55. Preuss K, et al. (2025) Pediatr Blood Cancer, 72: e31520. Available from: https://doi.org/10.1002/pbc.31520

Ref. 56. He Y, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1598. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0792

Ref. 57. Freedland AR, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1512. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0678

Ref. 58. Fejerman L, et al. (2022) Cancer Epidemiol Biomarkers Prev, 31: 932. Available from: https://doi.org/10.1158/1055-9965.EPI-21-1303

Ref. 59. Pacific Regional Central Cancer Registry. Cancer in the U.S. Affiliated Pacific Islands 2007-2022. Accessed: March 17, 2026. Available from: https://pacificcancer.org/_docs/pcp-publications/cip_07_22_061025.pdf

Ref. 60. University of Hawai‘i Cancer Center. Hawai‘i Cancer at a Glance 2014-2018. Accessed: March 17, 2026. Available from: https://www.uhcancercenter.org/pdf/archive/hitr//Cancer%20at%20a%20Glance%202014-2018.pdf

Ref. 61. Rezaei SJ, et al. (2024) JAMA Dermatol, 160: 1107. Available from: https://doi.org/10.1001/jamadermatol.2024.3043

Ref. 62. Lee E, et al. (2024) Cancer, 130: 1092. Available from: https://doi.org/10.1002/cncr.35141

Ref. 63. Choi HL, et al. (2025) JAMA Netw Open, 8: e2543559. Available from: https://doi.org/10.1001/jamanetworkopen.2025.43559

Ref. 64. Iwai Y, et al. (2024) Cancer Med, 13: e7428. Available from: https://doi.org/10.1002/cam4.7428

Ref. 65. US Department of Agriculture. Economic Research Service. Rural-Urban Continuum Codes. Accessed: March 17, 2026. Available from: https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/documentation

Ref. 66. Semprini J, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1012. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0072

Ref. 67. Islami F, et al. (2026) J Natl Cancer Inst. Available from: https://doi.org/10.1093/jnci/djag047

Ref. 68. Sellers ME, et al. (2025) J Natl Cancer Inst, 117: 2417. Available from: https://doi.org/10.1093/jnci/djaf258

Ref. 69. Islami F, et al. (2025) Cancer, 131: e70073. Available from: https://doi.org/10.1002/cncr.70073

Ref. 70. Gibson BJ, et al. (2025) J Rural Health, 41: e70102. Available from: https://doi.org/10.1111/jrh.70102

Ref. 71. National Cancer Institute. Division of Cancer Control and Population Sciences. Persistent Poverty. Accessed: March 31, 2026. Available from: https://cancercontrol.cancer.gov/research-emphasis/supplement/persistent-poverty-notice

Ref. 72. Unger JM, et al. (2025) CA Cancer J Clin, 75: 341. Available from: https://doi.org/10.3322/caac.70006

Ref. 73. Census.gov. Persistent Poverty in Counties and Census Tracts. Accessed: March 17, 2024. Available from: https://www.census.gov/content/dam/Census/library/publications/2023/acs/acs-51%20persistent%20poverty.pdf

Ref. 74. Dorali P, et al. (2025) JNCI Cancer Spectr, 9. Available from: https://doi.org/10.1093/jncics/pkaf091

Ref. 75. Karanth S, et al. (2024) Cancer Causes Control, 35: 1063. Available from: https://doi.org/10.1007/s10552-024-01867-3

Ref. 76. Chen JC, et al. (2024) JAMA Netw Open, 7: e2427755. Available from: https://doi.org/10.1001/jamanetworkopen.2024.27755

Ref. 77. Hymel E, et al. (2025) Pediatrics, 155. Available from: https://doi.org/10.1542/peds.2024-069973

Ref. 78. Naar L, et al. (2026) JAMA Netw Open, 9: e2551212. Available from: https://doi.org/10.1001/jamanetworkopen.2025.51212

Ref. 79. Tsai MH, et al. (2024) JAMA Netw Open, 7: e2430615. Available from: https://doi.org/10.1001/jamanetworkopen.2024.30615

Ref. 80. Bernacchi V, et al. (2025) BMC Public Health, 25: 878. Available from: https://doi.org/10.1186/s12889-025-22134-3

Ref. 81. Gallup. LGBTQ+ Identification in U.S. Rises to 9.3%. Accessed: March 31, 2026. Available from: https://news.gallup.com/poll/656708/lgbtq-identification-rises.aspx

Ref. 82. Huang AK, et al. (2024) Cancer, 130: 4306. Available from: https://doi.org/10.1002/cncr.35356

Ref. 83. Zamani SA, et al. (2025) J Natl Cancer Inst Monogr, 2025: 76. Available from: https://doi.org/10.1093/jncimonographs/lgaf017

Ref. 84. Simone NL, et al. (2025) J Natl Cancer Inst Monogr, 2025: 153. Available from: https://doi.org/10.1093/jncimonographs/lgaf030

Ref. 85. Yazdanpanah O, et al. (2023) Cancers (Basel), 15. Available from: https://doi.org/10.3390/cancers15092654

Ref. 86. Nik-Ahd F, et al. (2024) JAMA, 332: 335. Available from: https://doi.org/10.1001/jama.2024.9997

Ref. 87. Manfredi C, et al. (2024) JAMA Oncol, 10: 1697. Available from: https://doi.org/10.1001/jamaoncol.2024.4335

Ref. 88. Manfredi C, et al. (2023) Curr Oncol Rep, 25: 1431. Available from: https://doi.org/10.1007/s11912-023-01470-w

Ref. 89. Schroeder EW, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 2294. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0567

Ref. 90. Rypka KJ, et al. (2024) JAMA Dermatol, 160: 977. Available from: https://doi.org/10.1001/jamadermatol.2024.2097

Ref. 91. All of Us Research Program I, et al. (2019) N Engl J Med, 381: 668. Available from: https://doi.org/10.1056/NEJMsr1809937

Ref. 92. Tran NK, et al. (2023) JAMA Netw Open, 6: e2324969. Available from: https://doi.org/10.1001/jamanetworkopen.2023.24969

Ref. 93. Leone AG, et al. (2023) JAMA Oncol, 9: 556. Available from: https://doi.org/10.1001/jamaoncol.2022.7173

Ref. 94. Serchen J, et al. (2024) Ann Intern Med, 177: 1099. Available from: https://doi.org/10.7326/M24-0636

Ref. 95. Ngo P, et al. (2026) J Natl Cancer Inst Monogr, 2026: 3. Available from: https://doi.org/10.1093/jncimonographs/lgag005

Ref. 96. Kaur A, et al. (2023) Gynecol Oncol, 170: 266. Available from: https://doi.org/10.1016/j.ygyno.2023.01.032

Ref. 97. Parsons SK, et al. (2023) J Clin Oncol, 41: 3260. Available from: https://doi.org/10.1200/JCO.22.01985

Ref. 98. LaVeist TA, et al. (2023) JAMA, 329: 1682. Available from: https://doi.org/10.1001/jama.2023.5965

Ref. 99. Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Smedley BD, Stith AY, Nelson AR, editors. Washington (DC): National Academies Press (US); 2003. PMID: 25032386

Ref. 100. Committee on Educating Health Professionals to Address the Social Determinants of Health; Board on Global Health; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine. A Framework for Educating Health Professionals to Address the Social Determinants of Health. Washington (DC): National Academies Press (US); 2016 Oct 14. 1, Introduction. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395987/

Ref. 101. Krieger N (2012) Am J Public Health, 102: 936. Available from: https://doi.org/10.2105/ajph.2011.300544

Ref. 102. Krieger N (1999) Int J Health Serv, 29: 295. Available from: https://doi.org/10.2190/m11w-vwxe-kqm9-g97q

Ref. 103. Alvidrez J, et al. (2019) Am J Public Health, 109: S16. Available from: https://doi.org/10.2105/ajph.2018.304883

Ref. 104. Asare M, et al. (2017) Oncol Nurs Forum, 44: 20. Available from: https://doi.org/10.1188/17.Onf.20-23

Ref. 105. Winkfield KM, et al. (2021) JCO Oncology Practice, 17: e278. Available from: https://doi.org/10.1200/op.20.00630

Ref. 106. Warnecke RB, et al. (2008) Am J Public Health, 98: 1608. Available from: https://doi.org/10.2105/AJPH.2006.102525

Ref. 107. Bui LP, et al. (2024) Am J Clin Nutr, 120: 80. Available from: https://doi.org/10.1016/j.ajcnut.2024.03.019

Ref. 108. Cai Y, et al. (2024) Am J Clin Nutr, 119: 406. Available from: https://doi.org/10.1016/j.ajcnut.2023.11.015

Ref. 109. Fraser GE, et al. (2025) Am J Clin Nutr, 122: 535. Available from: https://doi.org/10.1016/j.ajcnut.2025.06.006

Ref. 110. Morales-Berstein F, et al. (2024) Eur J Nutr, 63: 377. Available from: https://doi.org/10.1007/s00394-023-03270-1

Ref. 111. Odoms-Young A, et al. (2024) The American Journal of Clinical Nutrition, 119: 850. Available from: https://doi.org/10.1016/j.ajcnut.2023.12.019

Ref. 112. Banegas MP, et al. (2024) JNCI Cancer Spectrum, 8. Available from: https://doi.org/10.1093/jncics/pkae115

Ref. 113. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Community-Based Solutions to Promote Health Equity in the United States. Communities in Action: Pathways to Health Equity. Baciu A, Negussie Y, Geller A, Weinstein JN, editors. Washington (DC): National Academies Press (US); 2017 Jan 11. PMID: 28418632

Ref. 114. Schaefer A, et al. (2025) Current Epidemiology Reports, 12: 7. Available from: https://doi.org/10.1007/s40471-025-00360-y

Ref. 115. Hernandez AE, et al. (2025) The Lancet Regional Health – Americas, 43. Available from: https://doi.org/10.1016/j.lana.2024.100962

Ref. 116. Mitchell B, et al. (2018)

Ref. 117. Bauer SJ, et al. (2025) Public Health, 238: 181. Available from: https://doi.org/10.1016/j.puhe.2024.10.022

Ref. 118. Kraus NT, et al. (2024) Public Health Nurs, 41: 287. Available from: https://doi.org/10.1111/phn.13276

Ref. 119. Karvonen KA, et al. (2025) Cancer, 131: e35677. Available from: https://doi.org/10.1002/cncr.35677

Ref. 120. Lima SM, et al. (2025) Cancer Causes Control, 36: 483. Available from: https://doi.org/10.1007/s10552-024-01950-9

Ref. 121. Lawrence WR, et al. (2025) Cancer, 131: e35850. Available from: https://doi.org/10.1002/cncr.35850

Ref. 122. Roland HB, et al. (2024) Cancer, 130: 4012. Available from: https://doi.org/10.1002/cncr.35512

Ref. 123. Miller-Kleinhenz JM, et al. (2024) JAMA Netw Open, 7: e2356879. Available from: https://doi.org/10.1001/jamanetworkopen.2023.56879

Ref. 124. Inclusive Action. Confronting Disaster. Curbing Corporate Speculation in Post-fire Altadena. Accessed: March 31, 2026. Available from: https://inclusiveaction.org/wp-content/uploads/2025/08/Confronting-Disaster-Curbing-Corporate-Speculation-in-Post-Fire-Altadena.pdf

Ref. 125. Strategic Actions for a Just Environment. Compounding Disaster. A Spatial Analysis of Housing Risk and Speculation in Post-fire Altadena. Accessed: March 31, 2026. Available from: https://www.saje.net/wp-content/uploads/2025/05/compounding-disaster-FINAL_WEB.pdf

Ref. 126. UCLA Center for Neighborhood Knowledge. LA Wildfires: Impacts on Altadena’s Black Community. Accessed: March 31, 2026. Available from: https://knowledge.luskin.ucla.edu/2025/01/27/data-brief-impacts-on-altadenas-black-community/

Ref. 127. Hernandez AE, et al. (2025) JAMA Network Open, 8: e2537378. Available from: https://doi.org/10.1001/jamanetworkopen.2025.37378

Ref. 128. Xiao Y, et al. (2025) JAMA Network Open, 8: e2518481. Available from: https://doi.org/10.1001/jamanetworkopen.2025.18481

Ref. 129. Zindani S, et al. (2025) J Surg Oncol, 131: 1110. Available from: https://doi.org/10.1002/jso.28039

Ref. 130. Nofi CP, et al. (2025) Journal of Pediatric Surgery, 60. Available from: https://doi.org/10.1016/j.jpedsurg.2025.162216

Ref. 131. Kwon C, et al. (2026) JAMA Health Forum, 7: e256935. Available from: https://doi.org/10.1001/jamahealthforum.2025.6935

Ref. 132. Centers for Disease Control and Prevention. Health Insurance Coverage: Early Release of Estimates From the National Health Interview Survey, January–June 2025. Accessed: March 31, 2026. Available from: https://www.cdc.gov/nchs/data/nhis/earlyrelease/Health-Insurance-Coverage-Early-Release-of-Estimates-January-June-2025.pdf

Ref. 133. Li S, et al. (2024) Nat Comm, 15: 9993. Available from: https://doi.org/10.1038/s41467-024-54444-2

Ref. 134. Lawler TP, et al. (2025) Social Science & Medicine, 381: 118212. Available from: https://doi.org/10.1016/j.socscimed.2025.118212

Ref. 135. Centers for Disease Control and Prevention. Percentage of disability status for adults aged 18 and over, United States, 2019, Jan-Jun—2025, Jan-Jun. National Health Interview Survey. Accessed: March 31, 2026. Available from: https://wwwn.cdc.gov/NHISDataQueryTool/ER_Biannual/index_biannual.html

Ref. 136. Xie Z, et al. (2025) LGBT Health, 12: 77. Available from: https://doi.org/10.1089/lgbt.2023.0166

Ref. 137. Silverwood SM, et al. (2024) Adv Radiat Oncol, 9: 101652. Available from: https://doi.org/10.1016/j.adro.2024.101652

Ref. 138. Harrell BJ, et al. (2025) JAMA Network Open, 8: e2532844. Available from: https://doi.org/10.1001/jamanetworkopen.2025.32844

Ref. 139. Frost DM, et al. (2023) Curr Opin Psychol, 51: 101579. Available from: https://doi.org/10.1016/j.copsyc.2023.101579

Ref. 140. McEwen BS, et al. (1993) Arch Intern Med, 153: 2093. Available from: https://doi.org/10.1001/archinte.1993.00410180039004

Ref. 141. Llanos AAM, et al. (2022) Front Oncol, 12: 857548. Available from: https://doi.org/10.3389/fonc.2022.857548

Ref. 142. Guan Y, et al. (2025) JAMA Network Open, 8: e2528019. Available from: https://doi.org/10.1001/jamanetworkopen.2025.28019

Ref. 143. Xing CY, et al. (2020) Breast Cancer Res Treat, 184: 901. Available from: https://doi.org/10.1007/s10549-020-05901-1

Ref. 144. Gormley M, et al. (2025) npj Breast Cancer, 11: 90. Available from: https://doi.org/10.1038/s41523-025-00812-0

Ref. 145. Barrett M, et al. (2022) Trends in Molecular Medicine, 28: 1040. Available from: https://doi.org/10.1016/j.molmed.2022.09.006

Ref. 146. Harris AR, et al. (2025) JAMA Netw Open, 8: e2459754. Available from: https://doi.org/10.1001/jamanetworkopen.2024.59754

Ref. 147. Duru OK, et al. (2012) J Natl Med Assoc, 104: 89. Available from: https://doi.org/10.1016/s0027-9684(15)30120-6

Ref. 148. Richardson LJ, et al. (2021) SSM – Population Health, 15: 100771. Available from: https://doi.org/10.1016/j.ssmph.2021.100771

Ref. 149. Beese S, et al. (2022) Int J Environ Res Public Health, 19. Available from: https://doi.org/10.3390/ijerph192417006

Ref. 150. Teferi HM, et al. (2026) Psychoneuroendocrinology, 183: 107661. Available from: https://doi.org/10.1016/j.psyneuen.2025.107661

Ref. 151. Obeng-Gyasi S, et al. (2021) npj Breast Cancer, 7: 100. Available from: https://doi.org/10.1038/s41523-021-00309-6

Ref. 152. Stabellini N, et al. (2023) JNCI Cancer Spectrum, 7: pkad005. Available from: https://doi.org/10.1093/jncics/pkad005

Ref. 153. Shen J, et al. (2025) Sci Rep, 15: 37505. Available from: https://doi.org/10.1038/s41598-025-21510-8

Ref. 154. Guan Y, et al. (2024) Cancers (Basel), 16. Available from: https://doi.org/10.3390/cancers16183235

Ref. 155. Sanogo F, et al. (2026) Cancer Res Commun, 6: 698. Available from: https://doi.org/10.1158/2767-9764.CRC-25-0388

Ref. 156. Yerger VB, et al. (2002) Tob Control, 11: 336. Available from: https://doi.org/10.1136/tc.11.4.336

Ref. 157. Haley SJ, et al. (2023) Int J Environ Res Public Health, 20. Available from: https://doi.org/10.3390/ijerph20043212

Ref. 158. Schwartz E, et al. (2021) Health Place, 68: 102529. Available from: https://doi.org/10.1016/j.healthplace.2021.102529

Ref. 159. Lane HM, et al. (2022) Environmental Science & Technology Letters, 9: 345. Available from: https://doi.org/10.1021/acs.estlett.1c01012

Ref. 160. Harris AR, et al. (2025) JAMA Netw Open, 8: e2461334. Available from: https://doi.org/10.1001/jamanetworkopen.2024.61334

Ref. 161. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2023. Accessed: March 17, 2024. Available from: https://health.gov/healthypeople/about

Ref. 162. Tamirisa N, et al. (2024) Ann Surg, 280: 136. Available from: https://doi.org/10.1097/SLA.0000000000006177

Ref. 163. Hussain MR, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17122003

Ref. 164. Graboyes EM, et al. (2022) J Natl Cancer Inst, 114: 1593. Available from: https://doi.org/10.1093/jnci/djac134

Ref. 165. Pringle S, et al. (2024) Support Care Cancer, 32: 317. Available from: https://doi.org/10.1007/s00520-024-08514-2

Ref. 166. US Department of Veterans Affairs. Veterans Transportation Program (VTP) – Health Benefits. Accessed: March 17, 2024. Available from: https://www.va.gov/healthbenefits/vtp/

Ref. 167. Gany FM, et al. (2020) J Health Care Poor Underserved, 31: 595. Available from: https://doi.org/10.1353/hpu.2020.0047

Ref. 168. Gany F, et al. (2022) Journal of Clinical Oncology, 40: 3603. Available from: https://doi.org/10.1200/Jco.21.02400

Ref. 169. Human Services Research Institute. Evaluation of the Louisiana Permanent Supportive Housing Initiative. Accessed: March 17, 2024. Available from: https://www.hsri.org//project/evaluation-of-the-louisiana-permanent-supportive-housing-initiative

Ref. 170. National Institutes of Health. NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men. Accessed: March 2017, 2024. Available from: https://www.nih.gov/news-events/news-releases/nih-prostate-cancer-foundation-launch-large-study-aggressive-prostate-cancer-african-american-men

Ref. 171. The Achieve Study. Assessing Cervical Cancer Healthcare Inequities in Diverse Populations. Accessed: March 31, 2026. Available from: https://www.theachievestudy.org/

Ref. 172. University of Hawai‘i Cancer Center. The Multiethnic Cohort Study. Accessed: March 26, 2024. Available from: https://www.uhcancercenter.org/mec

Ref. 173. Signorello LB, et al. (2010) J Health Care Poor Underserved, 21: 26. Available from: https://doi.org/10.1353/hpu.0.0245

Ref. 174. Science Insider. First long-term cancer study in Asian Americans set to launch this year. Accessed: March 31, 2026. Available from: https://www.science.org/content/article/first-long-term-cancer-study-asian-americans-set-launch-year

Ref. 175. Rosenberg L, et al. (1995) J Am Med Womens Assoc (1972), 50: 56

Ref. 176. All of Us Research Program. All of Us Genomic Quality Report. Accessed: March 31, 2026. Available from: https://support.researchallofus.org/hc/en-us/articles/29390274413716-All-of-Us-Genomic-Quality-Report

Ref. 177. All of Us Research Hub. All of Us Public Data Browser. Accessed: March 31, 2026. Available from: https://databrowser.researchallofus.org/ehr/conditions/CANCER

Ref. 178. McCullough LE, et al. (2025) Cancer, 131: e35775. Available from: https://doi.org/10.1002/cncr.35775

Ref. 179. Hensel B, et al. (2023) J Cancer Educ, 38: 1429. Available from: https://doi.org/10.1007/s13187-023-02351-3

Ref. 180. Allen JM, et al. (2025) J Cancer Educ. Available from: https://doi.org/10.1007/s13187-025-02676-1

Ref. 181. Centers for Disease Control and Prevention. Reducing Cancer Disparities Through Partnerships. Accessed: March 31, 2026. Available from: https://www.cdc.gov/cancer/health-equity/partnerships.html

Ref. 182. Centers for Disease Control and Prevention. REACH 2023 Program Recipients. Accessed: March 31, 2026. Available from: https://www.cdc.gov/reach/media/pdfs/2025/01/REACH-2023-recipient-project-profiles-508.pdf

Ref. 183. Palafox NA, et al. (2024) Cancer Control (Woodbridge), 2024: 59

Ref. 184. Qin J, et al. (2024) J Womens Health (Larchmt), 33: 839. Available from: https://doi.org/10.1089/jwh.2024.0284

Ref. 185. Division of Cancer Control and Population Sciences. Advancing Cancer Control Engaged Research through Transformative Solutions (ACCERT). Accessed: March 31, 2026. Available from: https://cancercontrol.cancer.gov/hd/research-emphasis/social-determinants-of-health/accert

Ref. 186. Hanahan D (2026) Cell. Available from: https://doi.org/10.1016/j.cell.2025.12.049

Ref. 187. Amuzu S, et al. (2025) Nat Genet, 57: 2655. Available from: https://doi.org/10.1038/s41588-025-02371-3

Ref. 188. Luo M, et al. (2025) Cancer Discov, 15: 511. Available from: https://doi.org/10.1158/2159-8290.CD-24-0827

Ref. 189. Wagner M, et al. (2025) J Natl Cancer Inst, 117: 1981. Available from: https://doi.org/10.1093/jnci/djaf141

Ref. 190. Turner DP, et al. (2024) Trends Cancer, 10: 673. Available from: https://doi.org/10.1016/j.trecan.2024.05.004

Ref. 191. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; National Cancer Policy Forum. Biological Effectors of Social Determinants of Health in Cancer: Identification and Mitigation: Proceedings of a Workshop. Nass S, Johnson A, Graig L, Balogh E, editors. Washington (DC): National Academies Press (US); 2025 Jan 15. PMID: 39446996

Ref. 192. National Academies of Sciences, Engineering, and Medicine. 2023. Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field. Washington, DC: The National Academies Press

Ref. 193. National Academies of Sciences, Engineering, and Medicine. 2025. Rethinking Race and Ethnicity in Biomedical Research. Washington, DC: The National Academies Press

Ref. 194. Lee KK, et al. (2022) Cancer Res, 82: 1222. Available from: https://doi.org/10.1158/0008-5472.CAN-21-2105

Ref. 195. Badal S, et al. (2025) Cancer Res Commun, 5: 1758. Available from: https://doi.org/10.1158/2767-9764.CRC-25-0254

Ref. 196. Madorsky Rowdo FP, et al. (2025) Cancer Res, 85: 551. Available from: https://doi.org/10.1158/0008-5472.CAN-24-0775

Ref. 197. Chung C, et al. (2026) Cancer Res Commun. Available from: https://doi.org/10.1158/2767-9764.CRC-25-0193

Ref. 198. Williams K, et al. (2025) Commun Biol, 8: 1324. Available from: https://doi.org/10.1038/s42003-025-08678-5

Ref. 199. Lott PC, et al. (2024) Cancer Res Commun, 4: 2147. Available from: https://doi.org/10.1158/2767-9764.CRC-23-0417

Ref. 200. Reams RR, et al. (2023) Cancer Control, 30: 10732748231197878. Available from: https://doi.org/10.1177/10732748231197878

Ref. 201. Nielsen R, et al. (2017) Nature, 541: 302. Available from: https://doi.org/10.1038/nature21347

Ref. 202. Timmermann A, et al. (2016) Nature, 538: 92. Available from: https://doi.org/10.1038/nature19365

Ref. 203. Liao WW, et al. (2023) Nature, 617: 312. Available from: https://doi.org/10.1038/s41586-023-05896-x

Ref. 204. Marx V (2026) Nat Methods, 23: 487. Available from: https://doi.org/10.1038/s41592-026-03021-0

Ref. 205. Logsdon GA, et al. (2025) Nature, 644: 430. Available from: https://doi.org/10.1038/s41586-025-09140-6

Ref. 206. Nassir N, et al. (2025) Nat Med, 31: 725. Available from: https://doi.org/10.1038/s41591-025-03544-7

Ref. 207. Gaye A, et al. (2024) Am J Hum Genet, 111: 2074. Available from: https://doi.org/10.1016/j.ajhg.2024.08.017

Ref. 208. Aryasomayajula C, et al. (2026) Gynecol Oncol, 204: 1. Available from: https://doi.org/10.1016/j.ygyno.2025.11.003

Ref. 209. Betti MJ, et al. (2025) Am J Hum Genet, 112: 2102. Available from: https://doi.org/10.1016/j.ajhg.2025.07.009

Ref. 210. Chen TY, et al. (2026) J Natl Cancer Inst. Available from: https://doi.org/10.1093/jnci/djag021

Ref. 211. Hoffmann TJ, et al. (2025) Nat Genet, 57: 334. Available from: https://doi.org/10.1038/s41588-024-02068-z

Ref. 212. Jia G, et al. (2024) Nat Genet, 56: 819. Available from: https://doi.org/10.1038/s41588-024-01736-4

Ref. 213. Jia G, et al. (2025) Nat Genet, 57: 80. Available from: https://doi.org/10.1038/s41588-024-02031-y

Ref. 214. Langie J, et al. (2026) Human Genetics and Genomics Advances, 7. Available from: https://doi.org/10.1016/j.xhgg.2025.100534

Ref. 215. de Smith AJ, et al. (2024) Cell Genomics, 4. Available from: https://doi.org/10.1016/j.xgen.2024.100526

Ref. 216. Im C, et al. (2025) Nat Commun, 16: 8974. Available from: https://doi.org/10.1038/s41467-025-64337-7

Ref. 217. Carrot-Zhang J, et al. (2020) Cancer Cell, 37: 639. Available from: https://doi.org/10.1016/j.ccell.2020.04.012

Ref. 218. Jain S, et al. (2024) JCO Precis Oncol, 8: e2400223. Available from: https://doi.org/10.1200/PO.24.00223

Ref. 219. Sisoudiya SD, et al. (2024) NPJ Precis Oncol, 8: 153. Available from: https://doi.org/10.1038/s41698-024-00644-4

Ref. 220. Ndahayo M, et al. (2026) Cancer Metastasis Rev, 45: 6. Available from: https://doi.org/10.1007/s10555-026-10312-7

Ref. 221. Thorn GJ, et al. (2025) Nat Commun, 16: 4237. Available from: https://doi.org/10.1038/s41467-025-59144-z

Ref. 222. Wen W, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 2208. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0345

Ref. 223. Brown LM, et al. (2024) Nat Commun, 15: 8218. Available from: https://doi.org/10.1038/s41467-024-52554-5

Ref. 224. Mandal S, et al. (2025) Cancer Res Commun, 5: 128. Available from: https://doi.org/10.1158/2767-9764.CRC-24-0376

Ref. 225. Elbialy A, et al. (2025) Cell Insight, 4: 100238. Available from: https://doi.org/10.1016/j.cellin.2025.100238

Ref. 226. Zhao J, et al. (2023) BMJ Oncol, 2: e000049. Available from: https://doi.org/10.1136/bmjonc-2023-000049

Ref. 227. Hein DM, et al. (2022) J Natl Cancer Inst, 114: 775. Available from: https://doi.org/10.1093/jnci/djac014

Ref. 228. Li J, et al. (2025) Lancet Oncol, 26: 1055. Available from: https://doi.org/10.1016/S1470-2045(25)00239-6

Ref. 229. Monge C, et al. (2025) Cancer Med, 14: e70791. Available from: https://doi.org/10.1002/cam4.70791

Ref. 230. Monge C, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17081325

Ref. 231. Monge C, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17071093

Ref. 232. Al Abo M, et al. (2025) NPJ Precis Oncol, 9: 30. Available from: https://doi.org/10.1038/s41698-025-00817-9

Ref. 233. Zeeshan S, et al. (2025) Oncogene, 44: 958. Available from: https://doi.org/10.1038/s41388-024-03267-y

Ref. 234. El Moheb M, et al. (2025) Ann Surg Oncol, 32: 736. Available from: https://doi.org/10.1245/s10434-024-16550-9

Ref. 235. Perkins CM, et al. (2026) Cancer Res Commun, 6: 165. Available from: https://doi.org/10.1158/2767-9764.CRC-25-0411

Ref. 236. Boyle J, et al. (2024) JAMA Netw Open, 7: e2421903. Available from: https://doi.org/10.1001/jamanetworkopen.2024.21903

Ref. 237. Zhao D, et al. (2025) Wiley Interdiscip Rev RNA, 16: e70028. Available from: https://doi.org/10.1002/wrna.70028

Ref. 238. Morgan RA, et al. (2025) Genes (Basel), 16. Available from: https://doi.org/10.3390/genes16020229

Ref. 239. Pacheco NL, et al. (2025) FASEB J, 39: e70366. Available from: https://doi.org/10.1096/fj.202402000R

Ref. 240. Zhong H, et al. (2025) Nat Commun. Available from: https://doi.org/10.1038/s41467-025-66250-5

Ref. 241. Satpathy S, et al. (2025) Cancer Cell, 43: 1731. Available from: https://doi.org/10.1016/j.ccell.2025.07.011

Ref. 242. Jia G, et al. (2025) Int J Cancer, 157: 2071. Available from: https://doi.org/10.1002/ijc.70041

Ref. 243. Craddock J, et al. (2025) Mol Syst Biol, 21: 1676. Available from: https://doi.org/10.1038/s44320-025-00153-x

Ref. 244. Chernoff M, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 428. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0288

Ref. 245. Huang H, et al. (2024) NPJ Genom Med, 9: 64. Available from: https://doi.org/10.1038/s41525-024-00448-2

Ref. 246. Hoos E, et al. (2025) Carcinogenesis, 46. Available from: https://doi.org/10.1093/carcin/bgaf004

Ref. 247. Kim SJ, et al. (2025) Cancer Prev Res (Phila). Available from: https://doi.org/10.1158/1940-6207.CAPR-25-0252

Ref. 248. Han YJ, et al. (2024) Clin Cancer Res, 30: 2609. Available from: https://doi.org/10.1158/1078-0432.CCR-23-1526

Ref. 249. Hu X, et al. (2026) Cell Rep, 45: 116882. Available from: https://doi.org/10.1016/j.celrep.2025.116882

Ref. 250. Zhu Q, et al. (2025) Nat Commun, 16: 6584. Available from: https://doi.org/10.1038/s41467-025-61034-3

Ref. 251. Trendowski MR, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1220. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0333

Ref. 252. Gao Z, et al. (2025) J Surg Res, 307: 21. Available from: https://doi.org/10.1016/j.jss.2025.01.005

Ref. 253. Falcone M, et al. (2024) Cancer Research, 84: 3924. Available from: https://doi.org/10.1158/0008-5472.Can-24-1359

Ref. 254. Zhong S, et al. (2025) Cell Rep Med, 6: 102217. Available from: https://doi.org/10.1016/j.xcrm.2025.102217

Ref. 255. Byrd D, et al. (2024) Nat Rev Cancer, 24: 89. Available from: https://doi.org/10.1038/s41568-023-00638-7

Ref. 256. Ramaboli MC, et al. (2024) Nat Commun, 15: 3379. Available from: https://doi.org/10.1038/s41467-024-46265-0

Ref. 257. Miya TV, et al. (2023) Cancers (Basel), 15. Available from: https://doi.org/10.3390/cancers15164086

Ref. 258. Laniewski P, et al. (2024) Cancer Prev Res (Phila), 17: 525. Available from: https://doi.org/10.1158/1940-6207.CAPR-24-0286

Ref. 259. Xu K, et al. (2025) Discover Oncology, 17: 59. Available from: https://doi.org/10.1007/s12672-025-04222-3

Ref. 260. Menghani SV (2025) The American Journal of the Medical Sciences, 369: 556. Available from: https://doi.org/10.1016/j.amjms.2025.01.001

Ref. 261. McDonald HG, et al. (2025) J Am Coll Surg, 240: 612. Available from: https://doi.org/10.1097/XCS.0000000000001299

Ref. 262. Abubakar M, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 462. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0390

Ref. 263. Parmar P, et al. (2026) NPJ Breast Cancer, 12: 3. Available from: https://doi.org/10.1038/s41523-025-00865-1

Ref. 264. Cobbs Ct, et al. (2025) Cancer Med, 14: e70979. Available from: https://doi.org/10.1002/cam4.70979

Ref. 265. Elias TM, et al. (2025) Biophotonics Discov, 2. Available from: https://doi.org/10.1117/1.bios.2.2.022703

Ref. 266. Barberena-Jonas C, et al. (2026) Nat Med, 32: 725. Available from: https://doi.org/10.1038/s41591-025-04100-z

Ref. 267. Kock KH, et al. (2025) Cell, 188: 2288. Available from: https://doi.org/10.1016/j.cell.2025.02.017

Ref. 268. Crossnohere NL, et al. (2025) Genet Med, 27: 101483. Available from: https://doi.org/10.1016/j.gim.2025.101483

Ref. 269. Penedo FJ, et al. (2024) Am J Epidemiol, 193: 940. Available from: https://doi.org/10.1093/aje/kwae033

Ref. 270. American Association for Cancer Research. AACR Project GENIE®. Accessed: March 31, 2026. Available from: https://www.aacr.org/professionals/research/aacr-project-genie/news-updates/

Ref. 271. Jones E, et al. (2026) JAMA Netw Open, 9: e260419. Available from: https://doi.org/10.1001/jamanetworkopen.2026.0419

Ref. 272. Lee JY, et al. (2025) NPJ Precis Oncol, 9: 347. Available from: https://doi.org/10.1038/s41698-025-01126-x

Ref. 273. Clavell-Revelles P, et al. (2025) Nat Commun, 16: 10194. Available from: https://doi.org/10.1038/s41467-025-66096-x

Ref. 274. American Association for Cancer Research. AACR Cancer Progress Report 2025. Accessed: March 31, 2026. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2025/09/AACR_CPR_2025.pdf

Ref. 275. Phillip G. Febbo et al. (2024) JCO Precis Oncol 8, e2300382. Available from: https://doi.org/10.1200/PO.23.00382

Ref. 276. Abdilleh K, et al. (2025) Clin Breast Cancer, 25: e301. Available from: https://doi.org/10.1016/j.clbc.2024.11.015

Ref. 277. Azarianpour S, et al. (2025) NPJ Precis Oncol, 9: 203. Available from: https://doi.org/10.1038/s41698-025-00972-z

Ref. 278. Lin SY, et al. (2025) Cell Rep Med, 6: 102527. Available from: https://doi.org/10.1016/j.xcrm.2025.102527

Ref. 279. Maracaja-Coutinho V, et al. (2026) Nat Rev Mol Cell Biol, 27: 1. Available from: https://doi.org/10.1038/s41580-025-00913-5

Ref. 280. Ngwa W, et al. (2024) Nat Med, 30: 2388. Available from: https://doi.org/10.1038/s41591-024-03119-y

Ref. 281. van Schaik LF, et al. (2025) JAMA Netw Open, 8: e2548538. Available from: https://doi.org/10.1001/jamanetworkopen.2025.48538

Ref. 282. Arora K, et al. (2025) JAMA Oncol, 11: 310. Available from: https://doi.org/10.1001/jamaoncol.2024.5794

Ref. 283. Davis MB, et al. (2025) Cancer Cell, 43: 619. Available from: https://doi.org/10.1016/j.ccell.2025.03.022

Ref. 284. Islami F, et al. (2024) CA Cancer J Clin, 74: 405. Available from: https://doi.org/10.3322/caac.21858

Ref. 285. American Association for Cancer Research. AACR Cancer Progress Report 2023. Accessed: March 31, 2026. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2023/10/AACR_CPR_2023_102423.pdf

Ref. 286. Swope CB, et al. (2022) J Urban Health, 99: 959. Available from: https://doi.org/10.1007/s11524-022-00665-z

Ref. 287. Trangenstein PJ, et al. (2020) Journal of Urban Health, 97: 123. Available from: https://doi.org/10.1007/s11524-019-00372-2

Ref. 288. Centers for Disease Control and Prevention. BRFSS Prevalence & Trends Data. Accessed: March 31, 2026. Available from: https://www.cdc.gov/brfss/brfssprevalence/index.html

Ref. 289. Nez Henderson P, et al. (2025) JNCI Monographs, 2025: 184. Available from: https://doi.org/10.1093/jncimonographs/lgaf024

Ref. 290. Fagan P, et al. (2025) JNCI Monographs, 2025: 187. Available from: https://doi.org/10.1093/jncimonographs/lgaf020

Ref. 291. Bandi P, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 836. Available from: https://doi.org/10.1158/1055-9965.EPI-24-1835

Ref. 292. Mansingka N, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17030534

Ref. 293. Agaku I, NEJM Evidence, 0: EVIDpha2500339. Available from: https://doi.org/doi:10.1056/EVIDpha2500339

Ref. 294. Patel M, et al. (2026) American Journal of Preventive Medicine, 70: 108160. Available from: https://doi.org/10.1016/j.amepre.2025.108160

Ref. 295. American Lung Association. State Rankings. Accessed: March 31, 2026. Available from: https://www.lung.org/research/sotc/state-grades/state-rankings

Ref. 296. US Food & Drug Administration. Scientific Review of the Effects of Menthol in Cigarettes on Tobacco Addiction: 1980-2021. Accessed: March 31, 2026. Available from: https://www.fda.gov/media/157642/download

Ref. 297. Bandi P, et al. (2025) Tob Control. Available from: https://doi.org/10.1136/tc-2024-059020

Ref. 298. Kathuria H, et al. (2024) Ann Am Thorac Soc, 21: 1245. Available from: https://doi.org/10.1513/AnnalsATS.202405-476ED

Ref. 299. Mendez D, et al. (2021) Tob Control. Available from: https://doi.org/10.1136/tobaccocontrol-2021-056748

Ref. 300. Mills SD, et al. (2025) Nicotine Tob Res, 27: 179. Available from: https://doi.org/10.1093/ntr/ntae011

Ref. 301. Page MK, et al. (2025) Tob Control, 34: 254. Available from: https://doi.org/10.1136/tc-2023-058149

Ref. 302. Bittoni MA, et al. (2024) J Oncol Res Ther, 9. Available from: https://doi.org/10.29011/2574-710x.10229

Ref. 303. Besaratinia A (2025) Chem Res Toxicol, 38: 542. Available from: https://doi.org/10.1021/acs.chemrestox.4c00520

Ref. 304. Jamal A, et al. (2024) MMWR Morb Mortal Wkly Rep, 73: 917. Available from: https://doi.org/10.15585/mmwr.mm7341a2

Ref. 305. Ali NS, et al. Chapter 23 – Betel Nut (Areca catechu) Usage and Its Effects on Health. In: Preedy VR, Watson RR, Patel VB, editors. Nuts and Seeds in Health and Disease Prevention. San Diego: Academic Press; 2011. p 197

Ref. 306. Wu N, et al. (2025) JAMA Intern Med, 185: 759. Available from: https://doi.org/10.1001/jamainternmed.2025.1599

Ref. 307. Moss WJ (2022) N Engl J Med, 387: 1059. Available from: https://doi.org/10.1056/NEJMp2203571

Ref. 308. National Cancer Institute Cancer Trends Progress Report. Secondhand Smoke Exposure. Accessed: March 31, 2026. Available from: https://progressreport.cancer.gov/prevention/tobacco/smoke_exposure

Ref. 309. National Institute on Drug Abuse. What are the effects of secondhand and thirdhand tobacco smoke? Accessed: March 31, 2026. Available from: https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-effects-secondhand-thirdhand-tobacco-smoke

Ref. 310. Arfaeinia H, et al. (2023) Environ Sci Pollut Res Int, 30: 78017. Available from: https://doi.org/10.1007/s11356-023-28128-1

Ref. 311. Tsai J, et al. (2021) Am. J. Prev. Med, 61: e109. Available from: https://doi.org/10.1016/j.amepre.2021.04.004

Ref. 312. Centers for Disease Control and Prevention. Trends and Disparities in Secondhand Smoke. Accessed: April 26, 2026. Available from: https://www.cdc.gov/tobacco/secondhand-smoke/disparities.html

Ref. 313. Goddard KAB, et al. (2025) JAMA Oncol, 11: 162. Available from: https://doi.org/10.1001/jamaoncol.2024.5381

Ref. 314. Soulakova JN, et al. (2017) Preventive Medicine Reports, 5: 160. Available from: https://doi.org/10.1016/j.pmedr.2016.12.008

Ref. 315. Kim N, et al. (2026) AJPM Focus, 5. Available from: https://doi.org/10.1016/j.focus.2025.100431

Ref. 316. Pati S, et al. (2023) Cancers (Basel), 15. Available from: https://doi.org/10.3390/cancers15020485

Ref. 317. Patel VR, et al. (2025) JAMA Internal Medicine, 185: 1370. Available from: https://doi.org/10.1001/jamainternmed.2025.4917

Ref. 318. Bacong AM, et al. (2024) JAMA Netw Open, 7: e240734. Available from: https://doi.org/10.1001/jamanetworkopen.2024.0734

Ref. 319. Centers for Disease Control and Prevention. Percentage of angina for adults aged 18 and over, United States, 2019—2024. Accessed: March 31, 2026. Available from: https://wwwn.cdc.gov/NHISDataQueryTool/SHS_adult/index.html

Ref. 320. DeCleene NK, et al. (2026) JAMA, 335: 975. Available from: https://doi.org/10.1001/jama.2025.26817

Ref. 321. Wilson RB, et al. (2023) Int J Mol Sci, 24. Available from: https://doi.org/10.3390/ijms24076192

Ref. 322. Lu Y, et al. (2022) Journal of the American Heart Association, 11: e025545. Available from: https://doi.org/doi:10.1161/JAHA.121.025545

Ref. 323. Kim C, et al. (2026) JAMA Pediatrics, 180: 334. Available from: https://doi.org/10.1001/jamapediatrics.2025.5708

Ref. 324. Jin Q, et al. (2023) Br J Cancer, 129: 1978. Available from: https://doi.org/10.1038/s41416-023-02469-7

Ref. 325. Chang K, et al. (2023) EClinicalMedicine, 56: 101840. Available from: https://doi.org/10.1016/j.eclinm.2023.101840

Ref. 326. Monteiro CA, et al. (2019) Public Health Nutr, 22: 936. Available from: https://doi.org/10.1017/s1368980018003762

Ref. 327. Ravandi B, et al. (2025) Nat Food, 6: 296. Available from: https://doi.org/10.1038/s43016-024-01095-7

Ref. 328. Wang T, et al. (2026) eClinicalMedicine, 91: 103700. Available from: https://doi.org/10.1016/j.eclinm.2025.103700

Ref. 329. Dunn CG, et al. (2021) American Journal of Preventive Medicine, 61: e197. Available from: https://doi.org/10.1016/j.amepre.2021.01.043

Ref. 330. Poorolajal J, et al. (2024) PLoS One, 19: e0305994. Available from: https://doi.org/10.1371/journal.pone.0305994

Ref. 331. Farvid MS, et al. (2021) European Journal of Epidemiology, 36: 937. Available from: https://doi.org/10.1007/s10654-021-00741-9

Ref. 332. Zouiouich S, et al. (2025) Current Developments in Nutrition, 9: 107540. Available from: https://doi.org/10.1016/j.cdnut.2025.107540

Ref. 333. Stewart H, et al. Trends in US Fruit Consumption Relative to Recommendations in the Dietary Guidelines for Americans. United States Department of Agriculture, Economic Research Service; 2024

Ref. 334. Lee SH, et al. (2022) Morb Mortal Wkly Rep, 71: 1. Available from: https://doi.org/10.15585/mmwr.mm7101a1

Ref. 335. Liu J, et al. (2024) Ann Intern Med, 177: 841. Available from: https://doi.org/10.7326/m24-0190

Ref. 336. Silva P, et al. (2023) Nutrients, 15. Available from: https://doi.org/10.3390/nu15224708

Ref. 337. Friedenreich CM, et al. (2021) Mol Oncol, 15: 790. Available from: https://doi.org/10.1002/1878-0261.12772

Ref. 338. Shreves AH, et al. (2025) British Journal of Sports Medicine, 59: 839. Available from: https://doi.org/10.1136/bjsports-2024-109360

Ref. 339. US Department of Health and Human Services. Physical Activity Guidelines for Americans 2nd edition. Accessed: March 31, 2026. Available from: https://odphp.health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf

Ref. 340. Kegler MC, et al. (2022) Prev Chronic Dis, 19: E40. Available from: https://doi.org/10.5888/pcd19.210417

Ref. 341. Patel NA, et al. (2022) Kans J Med, 15: 267. Available from: https://doi.org/10.17161/kjm.vol15.17592

Ref. 342. Jun S, et al. (2023) Epidemiol Health, 45: e2023092. Available from: https://doi.org/10.4178/epih.e2023092

Ref. 343. Bagnardi V, et al. (2015) Br J Cancer, 112: 580. Available from: https://doi.org/10.1038/bjc.2014.579

Ref. 344. Fokom Domgue J, et al. (2025) JAMA Oncology. Available from: https://doi.org/10.1001/jamaoncol.2025.4472

Ref. 345. National Institute on Alcohol Abuse and Alcoholism. Alcohol Use in the United States: Age Groups and Demographic Characteristics. Accessed: March 31, 2026. Available from: https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics-z/alcohol-facts-and-statistics/alcohol-use-united-states-age-groups-and-demographic-characteristics

Ref. 346. Desalu JM, et al. (2019) Addiction, 114: 957. Available from: https://doi.org/10.1111/add.14578

Ref. 347. Woodard N, et al. (2025) J Racial Ethn Health Disparities, 12: 3819. Available from: https://doi.org/10.1007/s40615-024-02180-0

Ref. 348. Panza KE, et al. (2022) Drug Alcohol Depend, 231: 109240. Available from: https://doi.org/10.1016/j.drugalcdep.2021.109240

Ref. 349. Bachrach RL, et al. (2018) J Subst Abuse Treat, 95: 18. Available from: https://doi.org/10.1016/j.jsat.2018.09.003

Ref. 350. Substance Abuse and Mental Health Service Administration. Mental Health and Substance Use among Veterans. Accessed: March 31, 2026. Available from: https://www.samhsa.gov/data/sites/default/files/reports/rpt56774/2024-nsduh-data-spotlight-veterans.pdf

Ref. 351. Carr MM, et al. (2021) Am J Addict, 30: 26. Available from: https://doi.org/10.1111/ajad.13067

Ref. 352. Dona AC, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 608. Available from: https://doi.org/10.1158/1055-9965.Epi-23-1264

Ref. 353. National Cancer Institute Cancer Trends Progress Report. Sunburn. Accessed: March 31, 2026. Available from: https://progressreport.cancer.gov/prevention/sun/sunburn

Ref. 354. Visser WI, et al. (2025) EJC Skin Cancer, 3: 100730. Available from: https://doi.org/10.1016/j.ejcskn.2025.100730

Ref. 355. Qian Y, et al. (2021) J Am Acad Dermatol, 84: 1585. Available from: https://doi.org/10.1016/j.jaad.2020.08.097

Ref. 356. Zhang K, et al. (2025) JMIR Cancer, 11: e67902. Available from: https://doi.org/10.2196/67902

Ref. 357. Fliorent R, et al. (2023) Cureus, 15: e33752. Available from: https://doi.org/10.7759/cureus.33752

Ref. 358. de Martel C, et al. (2020) The Lancet Global Health, 8: e180. Available from: https://doi.org/10.1016/S2214-109X(19)30488-7

Ref. 359. Hirth J (2019) Hum Vaccin Immunother, 15: 146. Available from: https://doi.org/10.1080/21645515.2018.1512453

Ref. 360. Cofie LE, et al. (2025) Frontiers in Public Health, Volume 13 – 2025. Available from: https://doi.org/10.3389/fpubh.2025.1604954

Ref. 361. Pingali C, et al. (2021) MMWR Morb Mortal Wkly Rep, 70: 1183. Available from: https://doi.org/10.15585/mmwr.mm7035a1

Ref. 362. Pingali C, et al. (2025) MMWR Morb Mortal Wkly Rep, 74: 466. Available from: https://doi.org/10.15585/mmwr.mm7430a1

Ref. 363. Sokale I, et al. (2025) Vaccines (Basel), 13. Available from: https://doi.org/10.3390/vaccines13020098

Ref. 364. Kreimer AR, et al. (2025) N Engl J Med, 393: 2421. Available from: https://doi.org/10.1056/NEJMoa2506765

Ref. 365. Fokom-Defo V, et al. (2024) The Lancet Global Health, 12: e360. Available from: https://doi.org/10.1016/S2214-109X(24)00009-3

Ref. 366. Stanley M, et al. (2024) Vaccine, 42: S16. Available from: https://doi.org/10.1016/j.vaccine.2024.01.046

Ref. 367. Palmer TJ, et al. (2024) JNCI: Journal of the National Cancer Institute, 116: 857. Available from: https://doi.org/10.1093/jnci/djad263

Ref. 368. TogetHER for Health. Operation Wipe Out: Statewide Action Plan to Eliminate Cervical Cancer in Alabama. Accessed: March 31, 2026. Available from: https://togetherforhealth.org/operation-wipe-out-statewide-action-plan-to-eliminate-cervical-cancer-in-alabama/

Ref. 369. Canfell K (2019) Papillomavirus Research, 8: 100170. Available from: https://doi.org/10.1016/j.pvr.2019.100170

Ref. 370. Gultekin M, et al. (2020) International Journal of Gynecological Cancer, 30: 426. Available from: https://doi.org/10.1136/ijgc-2020-001285

Ref. 371. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020

Ref. 372. Wilailak S, et al. (2025) Int J Gynaecol Obstet, 171 Suppl 1: 120. Available from: https://doi.org/10.1002/ijgo.70276

Ref. 373. Tsui J, et al. (2024) Prev Sci, 25: 147. Available from: https://doi.org/10.1007/s11121-023-01568-4

Ref. 374. Mohammed KA, et al. (2018) Preventive Medicine, 109: 39. Available from: https://doi.org/10.1016/j.ypmed.2018.01.016

Ref. 375. Centers for Disease Control and Prevention. Hepatitis B Surveillance. Accessed: March 31, 2026. Available from: https://www.cdc.gov/hepatitis-surveillance-2023/hepatitis-b/index.html

Ref. 376. Centers for Disease Control and Prevention. Hepatitis C Surveillance. Accessed: March 31, 2026. Available from: https://www.cdc.gov/hepatitis-surveillance-2023/hepatitis-c/index.html

Ref. 377. Burus T, et al. (2025) Journal of the American College of Surgeons, 240: 425. Available from: https://doi.org/10.1097/XCS.0000000000001273

Ref. 378. Jing W, et al. (2026) JHEP Reports, 8: 101754. Available from: https://doi.org/10.1016/j.jhepr.2026.101754

Ref. 379. Abboud Y, et al. (2024) J Clin Transl Hepatol, 12: 172. Available from: https://doi.org/10.14218/jcth.2023.00356

Ref. 380. US Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021–2025). Washington, DC. Accessed: March 31, 2026. Available from: https://www.hhs.gov/sites/default/files/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf

Ref. 381. Centers for Disease Control and Prevention. 2025 Strategic Plan. Division of Viral Hepatitis. Accessed: March 31, 2026. Available from: https://www.cdc.gov/hepatitis/media/DVH-StrategicPlan2020-2025.pdf

Ref. 382. IMPUS Health Services. IPUMS Health Surveys: National Health Interview Survey, Version 8.1 [2021 & 2023]. Accessed: March 31, 2026. Available from: https://nhis.ipums.org/nhis/sda.shtml

Ref. 383. Li D, et al. (2024) Gastro Hep Adv, 3: 749. Available from: https://doi.org/10.1016/j.gastha.2024.04.008

Ref. 384. Shah SC, et al. (2024) Clin Gastroenterol Hepatol, 22: 42. Available from: https://doi.org/10.1016/j.cgh.2023.05.016

Ref. 385. Brown H, et al. (2022) Gastro Hep Adv, 1: 857. Available from: https://doi.org/10.1016/j.gastha.2022.06.001

Ref. 386. Rammohan R, et al. (2023) Cureus, 15: e43080. Available from: https://doi.org/10.7759/cureus.43080

Ref. 387. Kumar S, et al. (2020) Gastroenterology, 158: 527. Available from: https://doi.org/10.1053/j.gastro.2019.10.019

Ref. 388. National Oceanic and Atmospheric Administration. Impacts, Risks, and Adaptation in the United States: Fourth National Climate Assessment, Volume II. Accessed: March 31, 2026. Available from: http://repository.library.noaa.gov/view/noaa/19487/noaa_19487_DS1.pdf

Ref. 389. Bernicker E, et al. (2024) JCO Oncology Practice, 20: 178. Available from: https://doi.org/10.1200/op.23.00637

Ref. 390. Stanford Cancer Institute. SCI 2022 Equity Impact Research Grant Challenge Award. Accessed: March 31, 2026. Available from: https://med.stanford.edu/cancer/research/funding/equity-impact/2022grand-challenge.html

Ref. 391. Patel R (2024) JCO Glob Oncol, 10: e2400455. Available from: https://doi.org/10.1200/GO-24-00455

Ref. 392. Moore MA, et al. (2010) Asian Pac J Cancer Prev, 11 Suppl 2: 99

Ref. 393. Department of Energy. Republic of the Marshall Islands Special Medical Care and Logistics Program Activities. Fiscal Year 2024. Accessed: March 31, 2026. Available from: https://www.energy.gov/sites/default/files/2025-06/FY 24 Annual Report to Congress on Marshall Islands Medical Program.pdf

Ref. 394. Yazzie SA, et al. (2020) Int J Environ Res Public Health, 17. Available from: https://doi.org/10.3390/ijerph17082813

Ref. 395. Centers for Disease Control and Prevention. Raising Radon Awareness in Tribal Communities. Accessed: March 31, 2026. Available from: https://www.cdc.gov/radon/features/tribal-communities.html

Ref. 396. Li L, et al. (2025) Proc Natl Acad Sci U S A, 122: e2408084121. Available from: https://doi.org/10.1073/pnas.2408084121

Ref. 397. Yang Z, et al. (2024) J Environ Radioact, 277: 107460. Available from: https://doi.org/10.1016/j.jenvrad.2024.107460

Ref. 398. Luo G, et al. (2025) Lancet Respir Med, 13: 348. Available from: https://doi.org/10.1016/S2213-2600(24)00428-4

Ref. 399. LoPiccolo J, et al. (2024) Nat Rev Clin Oncol, 21: 121. Available from: https://doi.org/10.1038/s41571-023-00844-0

Ref. 400. Zhang Y, et al. (2025) BMC Public Health, 25: 1260. Available from: https://doi.org/10.1186/s12889-025-22450-8

Ref. 401. Hill W, et al. (2023) Nature, 616: 159. Available from: https://doi.org/10.1038/s41586-023-05874-3

Ref. 402. Wu AH, et al. (2025) J Clin Oncol, 43: 273. Available from: https://doi.org/10.1200/JCO.24.00418

Ref. 403. Chan FY, et al. (2025) PLOS Glob Public Health, 5: e0004357. Available from: https://doi.org/10.1371/journal.pgph.0004357

Ref. 404. van Gerwen M, et al. (2023) EBioMedicine, 97: 104831. Available from: https://doi.org/10.1016/j.ebiom.2023.104831

Ref. 405. Liu B, et al. (2024) JAMA Netw Open, 7: e243127. Available from: https://doi.org/10.1001/jamanetworkopen.2024.3127

Ref. 406. Rhee J, et al. (2024) Environ Int, 192: 109058. Available from: https://doi.org/10.1016/j.envint.2024.109058

Ref. 407. Tanghal RB, et al. (2026) Environ Sci Technol, 60: 2816. Available from: https://doi.org/10.1021/acs.est.5c05535

Ref. 408. Binczewski NR, et al. (2026) J Expo Sci Environ Epidemiol. Available from: https://doi.org/10.1038/s41370-026-00850-1

Ref. 409. Zahm S, et al. (2024) Lancet Oncol, 25: 16. Available from: https://doi.org/10.1016/S1470-2045(23)00622-8

Ref. 410. Hu XC, et al. (2016) Environ Sci Technol Lett, 3: 344. Available from: https://doi.org/10.1021/acs.estlett.6b00260

Ref. 411. James P, et al. (2014) Health Place, 29: 10. Available from: https://doi.org/10.1016/j.healthplace.2014.04.011

Ref. 412. Santaliz Casiano A, et al. (2022) Endocrinology, 163. Available from: https://doi.org/10.1210/endocr/bqac034

Ref. 413. Johnson PI, et al. (2022) J Expo Sci Environ Epidemiol, 32: 864. Available from: https://doi.org/10.1038/s41370-022-00485-y

Ref. 414. Weiss MC, et al. (2023) Endocrinol Metab Clin North Am, 52: 719. Available from: https://doi.org/10.1016/j.ecl.2023.05.009

Ref. 415. Baan R, et al. (2009) Lancet Oncol, 10: 1143. Available from: https://doi.org/10.1016/s1470-2045(09)70358-4

Ref. 416. McDermott JE, et al. (2024) J Proteome Res, 23: 1547. Available from: https://doi.org/10.1021/acs.jproteome.3c00418

Ref. 417. National Toxicology P. NTP Cancer Hazard Assessment Report on Night Shift Work and Light at Night. Research Triangle Park (NC): National Toxicology Program; 2021

Ref. 418. Collatuzzo G, et al. (2022) Cancers (Basel), 14. Available from: https://doi.org/10.3390/cancers14174259

Ref. 419. Michaels D (1983) J Natl Med Assoc, 75: 1014

Ref. 420. Juon H-S, et al. (2021) Preventive Medicine, 143: 106355. Available from: https://doi.org/10.1016/j.ypmed.2020.106355

Ref. 421. Knox KE, et al. (2026) Journal of Exposure Science & Environmental Epidemiology, 36: 355. Available from: https://doi.org/10.1038/s41370-025-00808-9

Ref. 422. Phillips KA, et al. (2025) J Clin Oncol, 43: 422. Available from: https://doi.org/10.1200/JCO.24.00176

Ref. 423. Nichols HB, et al. (2019) Ann Intern Med, 170: 22. Available from: https://doi.org/10.7326/M18-1323

Ref. 424. Ambrosone CB, et al. (2020) Cancer Res, 80: 4871. Available from: https://doi.org/10.1158/0008-5472.CAN-20-0077

Ref. 425. Jung AY, et al. (2022) J Natl Cancer Inst, 114: 1706. Available from: https://doi.org/10.1093/jnci/djac117

Ref. 426. Millikan RC, et al. (2008) Breast Cancer Res Treat, 109: 123. Available from: https://doi.org/10.1007/s10549-007-9632-6

Ref. 427. Lord SJ, et al. (2008) Cancer Epidemiol Biomarkers Prev, 17: 1723. Available from: https://doi.org/10.1158/1055-9965.EPI-07-2824

Ref. 428. Fortner RT, et al. (2019) Breast Cancer Res, 21: 40. Available from: https://doi.org/10.1186/s13058-019-1119-y

Ref. 429. Masi AC, et al. (2024) Microb Biotechnol, 17: e14520. Available from: https://doi.org/10.1111/1751-7915.14520

Ref. 430. Anstey EH, et al. (2017) Am J Prev Med, 53: S40. Available from: https://doi.org/10.1016/j.amepre.2017.04.024

Ref. 431. Palmer JR, et al. (2014) J Natl Cancer Inst, 106. Available from: https://doi.org/10.1093/jnci/dju237

Ref. 432. World Cancer Research Fund. Research and Policy. Accessed: March 31, 2026. Available from: https://www.wcrf.org/research-policy/

Ref. 433. Babic A, et al. (2020) JAMA Oncol, 6: e200421. Available from: https://doi.org/10.1001/jamaoncol.2020.0421

Ref. 434. Campbell AG, et al. (2024) Breastfeeding Medicine, 19: 870. Available from: https://doi.org/10.1089/bfm.2024.0271

Ref. 435. Chlebowski RT, et al. (2020) JAMA, 324: 369. Available from: https://doi.org/10.1001/jama.2020.9482

Ref. 436. Chlebowski RT, et al. (2008) Arch Intern Med, 168: 370. Available from: https://doi.org/10.1001/archinternmed.2007.123

Ref. 437. Chlebowski RT, et al. (2009) N Engl J Med, 360: 573. Available from: https://doi.org/10.1056/NEJMoa0807684

Ref. 438. Collaborative Group on Hormonal Factors in Breast Cancer (2019) Lancet, 394: 1159. Available from: https://doi.org/10.1016/S0140-6736(19)31709-X

Ref. 439. Wang SM, et al. (2020) Breast Cancer Res, 22: 129. Available from: https://doi.org/10.1186/s13058-020-01365-9

Ref. 440. Green R, et al. (2010) Climacteric, 13: 376. Available from: https://doi.org/10.3109/13697130903528272

Ref. 441. Gold EB, et al. (2006) Am J Public Health, 96: 1226. Available from: https://doi.org/10.2105/ajph.2005.066936

Ref. 442. Blanken A, et al. (2022) Menopause, 29: 877. Available from: https://doi.org/10.1097/gme.0000000000001978

Ref. 443. Zahn K, et al. (2024) Maturitas, 186: 108021. Available from: https://doi.org/10.1016/j.maturitas.2024.108021

Ref. 444. Rodriguez MI, et al. (2024) Menopause, 31: 1062. Available from: https://doi.org/10.1097/gme.0000000000002437

Ref. 445. Jackson SS, et al. (2022) Trends Cancer, 8: 273. Available from: https://doi.org/10.1016/j.trecan.2022.01.005

Ref. 446. de Blok CJM, et al. (2019) BMJ, 365: l1652. Available from: https://doi.org/10.1136/bmj.l1652

Ref. 447. Vestering A, et al. (2025) EClinicalMedicine, 80: 103037. Available from: https://doi.org/10.1016/j.eclinm.2024.103037

Ref. 448. McGee R, et al. (1994) Social Science & Medicine, 38: 187. Available from: https://doi.org/10.1016/0277-9536(94)90314-X

Ref. 449. Oerlemans ME, et al. (2007) Clin Pract Epidemiol Ment Health, 3: 29. Available from: https://doi.org/10.1186/1745-0179-3-29

Ref. 450. Chida Y, et al. (2008) Nat Clin Pract Oncol, 5: 466. Available from: https://doi.org/10.1038/ncponc1134

Ref. 451. Dalton SO, et al. (2002) Eur J Cancer, 38: 1313. Available from: https://doi.org/10.1016/s0959-8049(02)00099-0

Ref. 452. Antoni MH, et al. (2023) Annu Rev Psychol, 74: 423. Available from: https://doi.org/10.1146/annurev-psych-030122-124119

Ref. 453. Mohan A, et al. (2022) Eur J Cancer Prev, 31: 585. Available from: https://doi.org/10.1097/CEJ.0000000000000752

Ref. 454. Vignjevic Petrinovic S, et al. (2023) Front Physiol, 14: 1119095. Available from: https://doi.org/10.3389/fphys.2023.1119095

Ref. 455. Boutelle KN, et al. (2000) Prev Med, 30: 217. Available from: https://doi.org/10.1006/pmed.1999.0618

Ref. 456. Ng DM, et al. (2003) Health Psychol, 22: 638. Available from: https://doi.org/10.1037/0278-6133.22.6.638

Ref. 457. Goel N, et al. (2024) J Clin Oncol, 42: 3618. Available from: https://doi.org/10.1200/JCO.23.02780

Ref. 458. Plascak JJ, et al. (2022) Cancer, 128: 131. Available from: https://doi.org/10.1002/cncr.33900

Ref. 459. Krueger PM, et al. (2008) Am J Public Health, 98: 889. Available from: https://doi.org/10.2105/AJPH.2007.114454

Ref. 460. Obeng-Gyasi S, et al. (2023) JAMA Network Open, 6: e2313989. Available from: https://doi.org/10.1001/jamanetworkopen.2023.13989

Ref. 461. Guan Y, et al. (2023) Breast Cancer Res, 25: 155. Available from: https://doi.org/10.1186/s13058-023-01754-w

Ref. 462. Obeng-Gyasi S, et al. (2022) JAMA Network Open, 5: e2221626. Available from: https://doi.org/10.1001/jamanetworkopen.2022.21626

Ref. 463. Parker HW, et al. (2022) Am J Prev Med, 63: 131. Available from: https://doi.org/10.1016/j.amepre.2022.02.003

Ref. 464. Li C, et al. (2023) BMC Women’s Health, 23: 448. Available from: https://doi.org/10.1186/s12905-023-02529-3

Ref. 465. Ishibe N, et al. (2025) American Journal of Epidemiology, 194: 1485. Available from: https://doi.org/10.1093/aje/kwaf038

Ref. 466. Knudsen MD, et al. (2025) JAMA Oncol, 11: 46. Available from: https://doi.org/10.1001/jamaoncol.2024.5227

Ref. 467. Huang S, et al. (2025) JAMA Netw Open, 8: e255322. Available from: https://doi.org/10.1001/jamanetworkopen.2025.5322

Ref. 468. Halpern MT, et al. (2024) Ann Intern Med, 177: 1170. Available from: https://doi.org/10.7326/M24-0375

Ref. 469. Rolle LD, et al. (2025) JAMA Oncol, 11: 784. Available from: https://doi.org/10.1001/jamaoncol.2025.0230

Ref. 470. Potter AL, et al. (2024) J Clin Oncol, 42: 2026. Available from: https://doi.org/10.1200/JCO.23.01780

Ref. 471. Potter AL, et al. (2025) Cancer, 131: e35676. Available from: https://doi.org/10.1002/cncr.35676

Ref. 472. Manful A, et al. (2026) Chest. Available from: https://doi.org/10.1016/j.chest.2026.01.006

Ref. 473. Lv XH, et al. (2025) Am J Gastroenterol. Available from: https://doi.org/10.14309/ajg.0000000000003429

Ref. 474. Alba C, et al. (2024) JAMA Health Forum, 5: e235058. Available from: https://doi.org/10.1001/jamahealthforum.2023.5058

Ref. 475. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2025-2026. Accessed: March 29, 2026. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-prevention-and-early-detection-facts-and-figures/2025-cped-files/cped-cff-2025-2026.pdf

Ref. 476. Gu T, et al. (2024) JAMA Netw Open, 7: e2451827. Available from: https://doi.org/10.1001/jamanetworkopen.2024.51827

Ref. 477. Sabatino SA, et al. (2025) Prev Chronic Dis, 22: E52. Available from: https://doi.org/10.5888/pcd22.250139

Ref. 478. Aaronson MRM, et al. (2025) Prev Med Rep, 50: 102976. Available from: https://doi.org/10.1016/j.pmedr.2025.102976

Ref. 479. Benavidez GA, et al. (2024) JNCI Cancer Spectr, 8. Available from: https://doi.org/10.1093/jncics/pkae113

Ref. 480. Shin E, et al. (2026) J Gen Intern Med. Available from: https://doi.org/10.1007/s11606-026-10355-0

Ref. 481. Decker H, et al. (2025) J Gen Intern Med, 40: 1297. Available from: https://doi.org/10.1007/s11606-024-09098-7

Ref. 482. Kincaid GE, et al. (2026) Health Promot Pract, 27: 94. Available from: https://doi.org/10.1177/15248399241306409

Ref. 483. Lui ML, et al. (2026) Cancer Epidemiol Biomarkers Prev, 35: 456. Available from: https://doi.org/10.1158/1055-9965.EPI-25-1457

Ref. 484. Su M, et al. (2025) Am J Prev Med, 69: 108014. Available from: https://doi.org/10.1016/j.amepre.2025.108014

Ref. 485. Lawson MB, et al. (2025) Radiology, 314: e241673. Available from: https://doi.org/10.1148/radiol.241673

Ref. 486. Aguilar-Romero C, et al. (2025) Psychooncology, 34: e70314. Available from: https://doi.org/10.1002/pon.70314

Ref. 487. Zhang H, et al. (2025) Cancer, 131: e35852. Available from: https://doi.org/10.1002/cncr.35852

Ref. 488. Amboree TL, et al. (2025) JAMA Netw Open, 8: e2526709. Available from: https://doi.org/10.1001/jamanetworkopen.2025.26709

Ref. 489. Issaka RB, et al. (2024) Cancer, 130: 4287. Available from: https://doi.org/10.1002/cncr.35514

Ref. 490. Mayer G, et al. (2025) Am Soc Clin Oncol Educ Book, 45: e473608. Available from: https://doi.org/10.1200/EDBK-25-473608

Ref. 491. LeBlanc ME, et al. (2025) Reprod Health, 22: 135. Available from: https://doi.org/10.1186/s12978-025-02082-2

Ref. 492. Vinson AH, et al. (2025) JAMA Netw Open, 8: e2457290. Available from: https://doi.org/10.1001/jamanetworkopen.2024.57290

Ref. 493. Schuering KM, et al. (2026) J Gen Intern Med. Available from: https://doi.org/10.1007/s11606-026-10272-2

Ref. 494. Suleman DB, et al. (2026) Palliat Support Care, 24: e68. Available from: https://doi.org/10.1017/S1478951526101849

Ref. 495. Cofie LE, et al. (2026) J Racial Ethn Health Disparities, 13: 117. Available from: https://doi.org/10.1007/s40615-024-02231-6

Ref. 496. Nassur J, et al. (2025) J Immigr Minor Health, 27: 609. Available from: https://doi.org/10.1007/s10903-025-01690-1

Ref. 497. Brennan L, et al. (2024) J Clin Transl Sci, 8: e118. Available from: https://doi.org/10.1017/cts.2024.604

Ref. 498. Cannizzaro NT, et al. (2024) J Womens Health (Larchmt), 33: 1614. Available from: https://doi.org/10.1089/jwh.2023.1180

Ref. 499. Michel AD, et al. (2024) Cancer, 130: 2325. Available from: https://doi.org/10.1002/cncr.35269

Ref. 500. Christine B, et al. (2026) JAMA, 335: 661. Available from: https://doi.org/10.1001/jama.2025.26456

Ref. 501. Wang YR (2025) Am J Manag Care, 31: e235. Available from: https://doi.org/10.37765/ajmc.2025.89779

Ref. 502. Siddique S, et al. (2024) JAMA Netw Open, 7: e2436358. Available from: https://doi.org/10.1001/jamanetworkopen.2024.36358

Ref. 503. Star J, et al. (2024) J Natl Cancer Inst, 116: 613. Available from: https://doi.org/10.1093/jnci/djae003

Ref. 504. Carethers JM, et al. (2026) Annu Rev Med, 77: 161. Available from: https://doi.org/10.1146/annurev-med-043024-032619

Ref. 505. Sepassi A et al. Oncologist. 29:e431. Available from: https://doi.org/10.1093/oncolo/oyad347

Ref. 506. Siddique S, et al. (2025) J Gen Intern Med, 40: 611. Available from: https://doi.org/10.1007/s11606-024-09153-3

Ref. 507. Zaire PJ, et al. (2026) Health Serv Res, 61: 1. Available from: https://doi.org/10.1111/1475-6773.70082

Ref. 508. Okitondo C, et al. (2025) J Cancer Policy, 43: 100516. Available from: https://doi.org/10.1016/j.jcpo.2024.100516

Ref. 509. Ciemins EL, et al. (2024) JAMA Netw Open, 7: e242693. Available from: https://doi.org/10.1001/jamanetworkopen.2024.2693

Ref. 510. Avilez L, et al. (2026) J Gen Intern Med. Available from: https://doi.org/10.1007/s11606-025-10116-5

Ref. 511. Issaka RB, et al. (2024) Clin Gastroenterol Hepatol, 22: 1967. Available from: https://doi.org/10.1016/j.cgh.2024.07.001

Ref. 512. Wang CP, et al. (2026) J Gen Intern Med. Available from: https://doi.org/10.1007/s11606-026-10226-8

Ref. 513. Alagoz O, et al. (2024) J Natl Cancer Inst, 116: 1807. Available from: https://doi.org/10.1093/jnci/djae140

Ref. 514. Bandi P, et al. (2025) JAMA, 334: 2225. Available from: https://doi.org/10.1001/jama.2025.19798

Ref. 515. Yambao Yang Y, et al. (2025) BMC Public Health, 25: 3978. Available from: https://doi.org/10.1186/s12889-025-24761-2

Ref. 516. Manful A, et al. (2026) J Natl Cancer Inst, 118: 343. Available from: https://doi.org/10.1093/jnci/djaf298

Ref. 517. Tasevac B, et al. (2024) CHEST Pulmonary, 2: 100051. Available from: https://doi.org/10.1016/j.chpulm.2024.100051

Ref. 518. Barrazueta SG, et al. (2026) J Racial Ethn Health Disparities, 13: 1527. Available from: https://doi.org/10.1007/s40615-025-02352-6

Ref. 519. Heintzman J, et al. (2025) J Am Board Fam Med, 38: 451. Available from: https://doi.org/10.3122/jabfm.2024.240376R1

Ref. 520. Gargapati A, et al. (2026) Cancers (Basel), 18. Available from: https://doi.org/10.3390/cancers18050864

Ref. 521. Gudina AT, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 35. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0725

Ref. 522. Aspiras O, et al. (2025) Psychol Health Med, 30: 1057. Available from: https://doi.org/10.1080/13548506.2024.2430889

Ref. 523. Sabakhtarishvili G, et al. (2025) JTO Clin Res Rep, 6: 100899. Available from: https://doi.org/10.1016/j.jtocrr.2025.100899

Ref. 524. Bhojani N, et al. (2025) Prostate Cancer Prostatic Dis, 28: 400. Available from: https://doi.org/10.1038/s41391-024-00843-x

Ref. 525. Lee JR, et al. (2025) JAMA Netw Open, 8: e2530946. Available from: https://doi.org/10.1001/jamanetworkopen.2025.30946

Ref. 526. VanderVeer-Harris N, et al. (2024) J Med Screen, 31: 239. Available from: https://doi.org/10.1177/09691413241248052

Ref. 527. Kratzer TB, et al. (2025) CA Cancer J Clin, 75: 485. Available from: https://doi.org/10.3322/caac.70028

Ref. 528. Oh CU, et al. (2025) Healthcare (Basel), 13. Available from: https://doi.org/10.3390/healthcare13121381

Ref. 529. Carethers JM (2025) Cancer Prev Res (Phila), 18: 313. Available from: https://doi.org/10.1158/1940-6207.CAPR-25-0007

Ref. 530. Lacombe-Duncan A, et al. (2025) Urol Oncol, 43: 664 e1. Available from: https://doi.org/10.1016/j.urolonc.2025.07.017

Ref. 531. Blackford AL, et al. (2024) JAMA Oncol, 10: 1087. Available from: https://doi.org/10.1001/jamaoncol.2024.1930

Ref. 532. Katona BW, et al. (2023) Cancer Prev Res (Phila), 16: 343. Available from: https://doi.org/10.1158/1940-6207.CAPR-22-0529

Ref. 533. Manam A, et al. (2025) JCO Precis Oncol, 9: e2500696. Available from: https://doi.org/10.1200/PO-25-00696

Ref. 534. Wagner IM, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 55. Available from: https://doi.org/10.1158/1055-9965.EPI-23-0596

Ref. 535. Rodriguez NJ, et al. (2025) Dig Dis Sci, 70: 2635. Available from: https://doi.org/10.1007/s10620-025-09018-7

Ref. 536. National Cancer Institute. Transforming Research into Community and Clinical Practice. Accessed: March 31, 2026. Available from: https://ebccp.cancercontrol.cancer.gov/index.do

Ref. 537. National Cancer Institute. Division of Cancer Control and Population Sciences. Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS). Accessed: March 31, 2026. Available from: https://healthcaredelivery.cancer.gov/accsis/

Ref. 538. Issaka RB, et al. (2025) JAMA Netw Open, 8: e2530515. Available from: https://doi.org/10.1001/jamanetworkopen.2025.30515

Ref. 539. Freeman HP, et al. (2011) Cancer, 117: 3539. Available from: https://doi.org/10.1002/cncr.26262

Ref. 540. Nelson HD, et al. (2025) JAMA Intern Med, 185: 976. Available from: https://doi.org/10.1001/jamainternmed.2025.1590

Ref. 541. Baggett TP, et al. (2024) JAMA Intern Med, 184: 892. Available from: https://doi.org/10.1001/jamainternmed.2024.1662

Ref. 542. Baggett TP, et al. (2015) Am J Prev Med, 49: 694. Available from: https://doi.org/10.1016/j.amepre.2015.03.038

Ref. 543. Reuland DS, et al. (2024) JAMA Netw Open, 7: e2446693. Available from: https://doi.org/10.1001/jamanetworkopen.2024.46693

Ref. 544. Montealegre JR, et al. (2025) JAMA Intern Med, 185: 1119. Available from: https://doi.org/10.1001/jamainternmed.2025.2971

Ref. 545. Coronado GD, et al. (2025) JAMA Netw Open, 8: e250928. Available from: https://doi.org/10.1001/jamanetworkopen.2025.0928

Ref. 546. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Policy and Global Affairs; Roundtable on Black Men and Black Women in Science, Engineering, and Medicine; Laurencin CT, Morgan RC Jr., Bright CM, editors. Leveraging Trust to Advance Science, Engineering, and Medicine in the Black Community: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2025 Jan 21. 3, Historical Roots of Medical Mistrust. Available from: https://www.ncbi.nlm.nih.gov/books/NBK611595/

Ref. 547. Hall MJ, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17040649

Ref. 548. Naserrudin NA, et al. (2025) Int J Public Health, 70: 1607763. Available from: https://doi.org/10.3389/ijph.2025.1607763

Ref. 549. Rink E, et al. (2024) Prev Sci, 25: 474. Available from: https://doi.org/10.1007/s11121-024-01668-9

Ref. 550. Ponce RKM, et al. (2025) J Community Health, 50: 750. Available from: https://doi.org/10.1007/s10900-025-01462-w

Ref. 551. Luque JS, et al. (2025) BMC Glob Public Health, 3: 47. Available from: https://doi.org/10.1186/s44263-025-00168-4

Ref. 552. Carter-Bawa L, et al. (2025) BMC Public Health, 25: 379. Available from: https://doi.org/10.1186/s12889-025-21623-9

Ref. 553. Dadha P, et al. (2026) PEC Innovation, 8: 100470. Available from: https://doi.org/10.1016/j.pecinn.2026.100470

Ref. 554. Holderness H, et al. (2025) Am J Prev Med, 70: 108241. Available from: https://doi.org/10.1016/j.amepre.2025.108241

Ref. 555. Huguet N, et al. (2026) JAMA Netw Open, 9: e2559100. Available from: https://doi.org/10.1001/jamanetworkopen.2025.59100

Ref. 556. Gann PH, et al. (2026) Cancer, 132: e70340. Available from: https://doi.org/10.1002/cncr.70340

Ref. 557. Choi E, et al. (2026) J Adolesc Young Adult Oncol, 15: 102. Available from: https://doi.org/10.1177/21565333251361619

Ref. 558. Japuntich SJ, et al. (2024) BMC Prim Care, 25: 202. Available from: https://doi.org/10.1186/s12875-024-02452-y

Ref. 559. Green AL, et al. (2026) J Gen Intern Med, 41: 767. Available from: https://doi.org/10.1007/s11606-025-09631-2

Ref. 560. van Lent LGG, et al. (2025) Patient Educ Couns, 136: 108767. Available from: https://doi.org/10.1016/j.pec.2025.108767

Ref. 561. Kim HS, et al. (2025) BJC Rep, 3: 80. Available from: https://doi.org/10.1038/s44276-025-00187-6

Ref. 562. Corredor-Waldron A, et al. (2026) Health Serv Res, 61: e70030. Available from: https://doi.org/10.1111/1475-6773.70030

Ref. 563. American Association for Cancer Research. AACR Pediatric Cancer Progress Report 2025. Accessed: March 17, 2026. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2025/12/AACR_PCPR_2025.pdf

Ref. 564. Barreto RB, et al. (2025) JCO Glob Oncol, 11: e2500326. Available from: https://doi.org/10.1200/GO-25-00326

Ref. 565. Abu Rous F, et al. (2024) JAMA Oncol, 10: 416. Available from: https://doi.org/10.1001/jamaoncol.2023.5778

Ref. 566. Adashek JJ, et al. (2019) Nat Rev Clin Oncol, 16: 773. Available from: https://doi.org/10.1038/s41571-019-0262-9

Ref. 567. Kingwell K (2022) Nat Rev Drug Discov, 21: 702. Available from: https://doi.org/10.1038/d41573-022-00144-9

Ref. 568. Nikanjam M, et al. (2025) CA Cancer J Clin, 75: 243. Available from: https://doi.org/10.3322/caac.21880

Ref. 569. Wagner MJ, et al. (2021) J Immunother Cancer, 9. Available from: https://doi.org/10.1136/jitc-2021-002990

Ref. 570. National Cancer Institute. NCI-MATCH Trial (Molecular Analysis for Therapy Choice). Accessed: March 31, 2026. Available from: https://www.cancer.gov/research/infrastructure/clinical-trials/featured/nci-match

Ref. 571. National Cancer Institute. Lung-MAP Clinical Trial. Accessed: March 31, 2026. Available from: https://www.cancer.gov/types/lung/research/lung-map

Ref. 572. Oxford Population Health. RECOVERY Trial. Accessed: March 31, 2026. Available from: https://www.recoverytrial.net/

Ref. 573. Wang H, et al. (2019) Curr Breast Cancer Rep, 11: 303. Available from: https://doi.org/10.1007/s12609-019-00334-2

Ref. 574. Dy GK, et al. (2023) J Clin Oncol, 41: 3311. Available from: https://doi.org/10.1200/JCO.22.02524

Ref. 575. Sicklick JK, et al. (2021) Genome Med, 13: 155. Available from: https://doi.org/10.1186/s13073-021-00969-w

Ref. 576. Unger JM, et al. (2024) J Clin Oncol, 42: 2139. Available from: https://doi.org/10.1200/JCO.23.01030

Ref. 577. Balogh EP, et al. (2025) JCO Oncol Pract, 21: 1746. Available from: https://doi.org/10.1200/OP-25-00233

Ref. 578. US Food & Drug Administration. July 17, 2025: Meeting of the Oncologic Drugs Advisory Committee – 07/17/2025. Accessed: March 31, 2026. Available from: https://www.fda.gov/advisory-committees/july-17-2025-meeting-oncologic-drugs-advisory-committee-07172025#event-information

Ref. 579. US Food & Drug Administration. May 20-21, 2025: Meeting of the Oncologic Drugs Advisory Committee – 05/20/2025. Accessed: March 31, 2026. Available from: https://www.fda.gov/advisory-committees/advisory-committee-calendar/may-20-21-2025-meeting-oncologic-drugs-advisory-committee-05202025

Ref. 580. Hanshaw BD, et al. (2025) Nat Med, 31: 720. Available from: https://doi.org/10.1038/s41591-024-03471-z

Ref. 581. IQVIA. Advancing Precision Oncology. Trends in Oncology Biomarker Testing in the U.S. Accessed: March 31, 2026. Available from: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/advancing-precision-oncology

Ref. 582. Patiyal S, et al. (2026) Sci Rep, 16. Available from: https://doi.org/10.1038/s41598-026-39609-x

Ref. 583. Monreal I, et al. (2025) Mil Med, 190: e891. Available from: https://doi.org/10.1093/milmed/usae441

Ref. 584. Bruno DS, et al. (2025) Hematology, 30: 2457809. Available from: https://doi.org/10.1080/16078454.2025.2457809

Ref. 585. Chua AV, Jr., et al. (2025) JCO Oncol Pract, 21: 408. Available from: https://doi.org/10.1200/op.24.00033

Ref. 586. Farooq M, et al. (2025) Cancer Discov, 15: 2251. Available from: https://doi.org/10.1158/2159-8290.CD-25-0112

Ref. 587. Gopishetty S, et al. (2020) Am J Transl Res, 12: 5977

Ref. 588. Gong IY, et al. (2025) Cancer, 131: e70204. Available from: https://doi.org/10.1002/cncr.70204

Ref. 589. Levin G, et al. (2025) Am J Obstet Gynecol, 233: 110 e1. Available from: https://doi.org/10.1016/j.ajog.2025.01.026

Ref. 590. Taira DA, et al. (2024) JAMA Netw Open, 7: e2442204. Available from: https://doi.org/10.1001/jamanetworkopen.2024.42204

Ref. 591. US Food & Drug Administration. Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies. Accessed: March 31, 2026. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-action-plans-improve-enrollment-participants-underrepresented-populations-clinical-studies

Ref. 592. US Food & Drug Administration. Drug Trials Snapshots: VYLOY. Accessed: March 31, 2026. Available from: https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-vyloy

Ref. 593. US Food & Drug Administration. Drug Trials Snapshots: DATROWAY. Accessed: March 31, 2026. Available from: https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-datroway

Ref. 594. Goel S, et al. (2024) JAMA Netw Open, 7: e2421485. Available from: https://doi.org/10.1001/jamanetworkopen.2024.21485

Ref. 595. Kirkwood MK, et al. (2025) JCO Oncol Pract, 21: 427. Available from: https://doi.org/10.1200/OP.24.00261

Ref. 596. Kirkwood MK, et al. (2025) JCO Oncol Pract, 21: 1775. Available from: https://doi.org/10.1200/OP-25-00144

Ref. 597. Thapar R, et al. (2025) Proc (Bayl Univ Med Cent), 38: 929. Available from: https://doi.org/10.1080/08998280.2025.2547162

Ref. 598. Akimoto K, et al. (2023) Cancer J, 29: 310. Available from: https://doi.org/10.1097/PPO.0000000000000675

Ref. 599. Rosser BRS, et al. (2023) J Clin Oncol, 41: 5093. Available from: https://doi.org/10.1200/JCO.23.00655

Ref. 600. Dong W, et al. (2025) J Natl Compr Canc Netw, 24. Available from: https://doi.org/10.6004/jnccn.2025.7092

Ref. 601. Chen N, et al. (2025) JAMA Netw Open, 8: e2515205. Available from: https://doi.org/10.1001/jamanetworkopen.2025.15205

Ref. 602. Guadamuz JS, et al. (2024) JNCI Cancer Spectr, 8. Available from: https://doi.org/10.1093/jncics/pkae085

Ref. 603. Zhao Y, et al. (2025) Cancer, 131: e35944. Available from: https://doi.org/10.1002/cncr.35944

Ref. 604. Coley AK, et al. (2023) JCO Oncol Pract, 19: 154. Available from: https://doi.org/10.1200/OP.22.00785

Ref. 605. Castillo BS, et al. (2024) Curr Oncol, 31: 3017. Available from: https://doi.org/10.3390/curroncol31060230

Ref. 606. Mesa R, et al. (2023) Trans Am Clin Climatol Assoc, 133: 149

Ref. 607. Verdini NP, et al. (2024) Int J Radiat Oncol Biol Phys, 119: 11. Available from: https://doi.org/10.1016/j.ijrobp.2023.09.025

Ref. 608. Bylund CL, et al. (2017) Clin Trials, 14: 518. Available from: https://doi.org/10.1177/1740774517717722

Ref. 609. Myers R, et al. (2023) Contemp Clin Trials Commun, 34: 101183. Available from: https://doi.org/10.1016/j.conctc.2023.101183

Ref. 610. Saez-Ibanez AR, et al. (2022) Nat Rev Drug Discov, 21: 870. Available from: https://doi.org/10.1038/d41573-022-00189-w

Ref. 611. Shriver SP, et al. (2025) J Clin Transl Sci, 9: e218. Available from: https://doi.org/10.1017/cts.2025.10148

Ref. 612. Lee H, et al. (2024) JAMA Oncol, 10: 652. Available from: https://doi.org/10.1001/jamaoncol.2023.7314

Ref. 613. Perati SR, et al. (2025) J Natl Cancer Inst. Available from: https://doi.org/10.1093/jnci/djaf355

Ref. 614. Sekar RR, et al. (2025) J Natl Cancer Inst, 117: 1934. Available from: https://doi.org/10.1093/jnci/djaf047

Ref. 615. Jin S, et al. (2017) J Clin Oncol, 35: 3745. Available from: https://doi.org/10.1200/JCO.2017.73.4186

Ref. 616. Riner AN, et al. (2022) J Clin Oncol, 40: 2193. Available from: https://doi.org/10.1200/JCO.21.02492

Ref. 617. Lim E, et al. (2015) Hawaii J Med Public Health, 74: 302

Ref. 618. Riner AN, et al. (2023) JNCI Cancer Spectr, 7. Available from: https://doi.org/10.1093/jncics/pkad009

Ref. 619. Unger JM (2025) JAMA Netw Open, 8: e2515210. Available from: https://doi.org/10.1001/jamanetworkopen.2025.15210

Ref. 620. Unger JM, et al. (2023) J Clin Oncol, 41: 2020. Available from: https://doi.org/10.1200/JCO.22.01826

Ref. 621. Abdou Y, et al. (2024) J Clin Oncol, 42: 3887. Available from: https://doi.org/10.1200/JCO-24-01484

Ref. 622. George TJ, et al. (2025) J Natl Cancer Inst, 117: 1533. Available from: https://doi.org/10.1093/jnci/djaf114

Ref. 623. Unger JM, et al. (2024) J Clin Oncol, 42: 3917. Available from: https://doi.org/10.1200/JCO.24.00843

Ref. 624. Lupo PJ, et al. (2025) J Natl Cancer Inst, 117: 1868. Available from: https://doi.org/10.1093/jnci/djaf134

Ref. 625. Fashoyin-Aje LA, et al. (2024) JAMA Oncol, 10: 380. Available from: https://doi.org/10.1001/jamaoncol.2023.5781

Ref. 626. Faulk KE, et al. (2020) PLoS One, 15: e0230824. Available from: https://doi.org/10.1371/journal.pone.0230824

Ref. 627. Wyatt KD, et al. (2024) JCO Oncol Pract, 20: 603. Available from: https://doi.org/10.1200/OP.23.00826

Ref. 628. Monroe C, et al. (2025) Pediatr Blood Cancer, 72: e31641. Available from: https://doi.org/10.1002/pbc.31641

Ref. 629. Santacroce SJ, et al. (2024) Pediatr Blood Cancer, 71: e31321. Available from: https://doi.org/10.1002/pbc.31321

Ref. 630. Beauchemin MP, et al. (2024) JNCI Cancer Spectr, 8. Available from: https://doi.org/10.1093/jncics/pkae047

Ref. 631. Umaretiya PJ, et al. (2025) JAMA Netw Open, 8: e2458531. Available from: https://doi.org/10.1001/jamanetworkopen.2024.58531

Ref. 632. Shoag J, et al. (2024) Pediatr Blood Cancer, 71: e31192. Available from: https://doi.org/10.1002/pbc.31192

Ref. 633. Unger JM, et al. (2021) J Clin Oncol, 39: 1339. Available from: https://doi.org/10.1200/JCO.20.02602

Ref. 634. Lipsyc-Sharf M, et al. (2023) JAMA Netw Open, 6: e2339584. Available from: https://doi.org/10.1001/jamanetworkopen.2023.39584

Ref. 635. Tucker-Seeley R, et al. (2024) JCO Oncol Pract, 20: 621. Available from: https://doi.org/10.1200/OP.23.00810

Ref. 636. Smith H, et al. (2024) J Gastrointest Cancer, 56: 24. Available from: https://doi.org/10.1007/s12029-024-01146-z

Ref. 637. Nouvini R, et al. (2022) Cancer, 128: 3860. Available from: https://doi.org/10.1002/cncr.34454

Ref. 638. Guerra CE, et al. Journal of Clinical Oncology, 39: 100. Available from: https://doi.org/10.1200/JCO.2021.39.15_suppl.100

Ref. 639. Taylor S, et al. (2025) J Clin Transl Sci, 9: e156. Available from: https://doi.org/10.1017/cts.2025.10085

Ref. 640. Muhigaba PB, et al. (2025) J Clin Transl Sci, 9: e221. Available from: https://doi.org/10.1017/cts.2025.10140

Ref. 641. Becker M, et al. (2025) Cancer Epidemiology, Biomarkers & Prevention, 34: B094. Available from: https://doi.org/10.1158/1538-7755.Disp25-b094

Ref. 642. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Board on Health Care Services; Committee on Unequal Treatment Revisited: The Current State of Racial and Ethnic Disparities in Health Care. Ending Unequal Treatment: Strategies to Achieve Equitable Health Care and Optimal Health for All. Nass SJ, Amankwah FK, DeVoe JE, Benjamin GC, editors. Washington (DC): National Academies Press (US); 2024 Aug 23. PMID: 38924457

Ref. 643. Makhnoon S, et al. (2025) Cancer Med, 14: e71125. Available from: https://doi.org/10.1002/cam4.71125

Ref. 644. Boitano TKL, et al. (2025) Int J Gynecol Cancer, 35: 100066. Available from: https://doi.org/10.1016/j.ijgc.2024.100066

Ref. 645. Khan MMM, et al. (2024) J Gastrointest Surg, 28: 896. Available from: https://doi.org/10.1016/j.gassur.2024.03.027

Ref. 646. Ledesma Vicioso N, et al. (2022) JCO Oncol Pract, 18: e780. Available from: https://doi.org/10.1200/OP.22.00037

Ref. 647. American Association for Cancer Research. AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care. Accessed: March 31, 2026. Available from: https://www.aacr.org/professionals/research/aacr-covid-19-and-cancer-report-2022/

Ref. 648. Aiyegbusi OL, et al. (2024) Nat Med, 30: 3075. Available from: https://doi.org/10.1038/s41591-024-03323-w

Ref. 649. Morrison JK, et al. (2026) The Oncologist: oyag118. Available from: https://doi.org/10.1093/oncolo/oyag118

Ref. 650. Jillella AP, et al. (2025) JAMA Oncol, 11: 400. Available from: https://doi.org/10.1001/jamaoncol.2024.7033

Ref. 651. Kaur M, et al. (2024) NEJM Evid, 3: EVIDoa2300236. Available from: https://doi.org/10.1056/EVIDoa2300236

Ref. 652. van Berge Henegouwen JM, et al. (2024) Clin Cancer Res, 30: 3937. Available from: https://doi.org/10.1158/1078-0432.CCR-23-3917

Ref. 653. Verdini NP, et al. (2024) JAMA Oncol, 10: 784. Available from: https://doi.org/10.1001/jamaoncol.2024.0280

Ref. 654. Abbidi SR, et al. (2026) Trials, 27. Available from: https://doi.org/10.1186/s13063-026-09537-2

Ref. 655. Chow R, et al. (2023) J Natl Cancer Inst, 115: 365. Available from: https://doi.org/10.1093/jnci/djad013

Ref. 656. Gong G, et al. (2026) JCO Clin Cancer Inform, 10: e2500262. Available from: https://doi.org/10.1200/CCI-25-00262

Ref. 657. Schpero WL, et al. (2024) J Clin Oncol, 42: 3238. Available from: https://doi.org/10.1200/JCO.23.01149

Ref. 658. Montano-Campos JF, et al. (2026) J Natl Compr Canc Netw, 24. Available from: https://doi.org/10.6004/jnccn.2025.7109

Ref. 659. Loeb S, et al. (2023) JAMA Netw Open, 6: e2324395. Available from: https://doi.org/10.1001/jamanetworkopen.2023.24395

Ref. 660. Kuri L, et al. (2023) Clin Trials, 20: 585. Available from: https://doi.org/10.1177/17407745231180506

Ref. 661. Moen EL, et al. (2025) JAMA Netw Open, 8: e2461021. Available from: https://doi.org/10.1001/jamanetworkopen.2024.61021

Ref. 662. Leonis R, et al. (2025) Am Surg, 91: 746. Available from: https://doi.org/10.1177/00031348251318376

Ref. 663. Nguyen A, et al. (2025) J Surg Oncol, 131: 1002. Available from: https://doi.org/10.1002/jso.27994

Ref. 664. Lynch OF, et al. (2026) JAMA Netw Open, 9: e2559845. Available from: https://doi.org/10.1001/jamanetworkopen.2025.59845

Ref. 665. Ajjawi I, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17091579

Ref. 666. Dirican CD, et al. (2026) Urologic Oncology: Seminars and Original Investigations: 111088. Available from: https://doi.org/10.1016/j.urolonc.2026.111088

Ref. 667. Abdel-Rahman O, et al. (2026) J Racial Ethn Health Disparities. Available from: https://doi.org/10.1007/s40615-026-02847-w

Ref. 668. Tsai MH, et al. (2026) JAMA Netw Open, 9: e261980. Available from: https://doi.org/10.1001/jamanetworkopen.2026.1980

Ref. 669. LeBlanc MR, et al. (2026) Cancer Med, 15: e71563. Available from: https://doi.org/10.1002/cam4.71563

Ref. 670. Wang Y, et al. (2025) Cancer Med, 14: e71354. Available from: https://doi.org/10.1002/cam4.71354

Ref. 671. Parikh-Patel A, et al. (2026) Am J Prev Med: 108333. Available from: https://doi.org/10.1016/j.amepre.2026.108333

Ref. 672. da Costa WL, Jr., et al. (2024) J Surg Oncol, 129: 1542. Available from: https://doi.org/10.1002/jso.27683

Ref. 673. Herb J, et al. (2025) JCO Oncol Pract: OP2500351. Available from: https://doi.org/10.1200/OP-25-00351

Ref. 674. Bhadouriya R, et al. (2025) Ann Surg Oncol, 32: 4034. Available from: https://doi.org/10.1245/s10434-025-17152-9

Ref. 675. Starr S, et al. (2025) Urology, 204: 121. Available from: https://doi.org/10.1016/j.urology.2025.06.021

Ref. 676. Reeder-Hayes KE, et al. (2024) J Clin Oncol, 42: 3858. Available from: https://doi.org/10.1200/JCO.23.02483

Ref. 677. Yen TWF, et al. (2025) Breast Cancer Res Treat, 215: 40. Available from: https://doi.org/10.1007/s10549-025-07863-8

Ref. 678. Manisundaram NV, et al. (2025) Ann Surg Oncol, 32: 6807. Available from: https://doi.org/10.1245/s10434-025-17555-8

Ref. 679. Zhang FG, et al. (2024) JCO Oncology Practice, 20: 1733. Available from: https://doi.org/10.1200/op.24.00118

Ref. 680. Crowley RJ, et al. (2026) J Cancer Policy, 47: 100704. Available from: https://doi.org/10.1016/j.jcpo.2026.100704

Ref. 681. Montano-Campos JF, et al. (2025) JAMA Netw Open, 8: e258039. Available from: https://doi.org/10.1001/jamanetworkopen.2025.8039

Ref. 682. KFF. Survey on Racism, Discrimination and Health: Experiences and Impacts Across Racial and Ethnic Groups. Available from: https://www.kff.org/racial-equity-and-health-policy/survey-on-racism-discrimination-and-health/

Ref. 683. Insalaco ME, et al. (2026) Oncologist, 31. Available from: https://doi.org/10.1093/oncolo/oyag063

Ref. 684. Brown-Savita M, et al. (2026) Cancers (Basel), 18. Available from: https://doi.org/10.3390/cancers18030398

Ref. 685. Burotto M, et al. (2019) Semin Oncol, 46: 83. Available from: https://doi.org/10.1053/j.seminoncol.2019.01.002

Ref. 686. De Jesus EM, et al. (2025) Ann Surg Oncol, 32: 8621. Available from: https://doi.org/10.1245/s10434-025-18157-0

Ref. 687. Orsi C, et al. (2025) Ann Surg Oncol, 32: 4883. Available from: https://doi.org/10.1245/s10434-025-17291-z

Ref. 688. Keane CA, et al. (2026) Clin Breast Cancer, 26: 45. Available from: https://doi.org/10.1016/j.clbc.2025.11.012

Ref. 689. Patel VR, et al. (2025) Ann Surg, 281: 711. Available from: https://doi.org/10.1097/SLA.0000000000006516

Ref. 690. Singh A, et al. (2026) Ann Surg Oncol. Available from: https://doi.org/10.1245/s10434-026-19411-9

Ref. 691. Boyd M, et al. (2026) Cancer Causes Control, 37: 49. Available from: https://doi.org/10.1007/s10552-026-02127-2

Ref. 692. Azam S, et al. (2026) Br J Cancer. Available from: https://doi.org/10.1038/s41416-026-03380-7

Ref. 693. Kumar N, et al. (2025) Neurosurg Rev, 48: 334. Available from: https://doi.org/10.1007/s10143-025-03477-2

Ref. 694. Stuart CM, et al. (2025) Ann Thorac Surg, 119: 1082. Available from: https://doi.org/10.1016/j.athoracsur.2024.12.009

Ref. 695. Potter AL, et al. (2024) J Thorac Cardiovasc Surg, 167: 1603. Available from: https://doi.org/10.1016/j.jtcvs.2023.08.059

Ref. 696. Association of American Medical Colleges. The Complexities of Physician Supply and Demand: Projections From 2021 to 2036 Summary Report. Accessed: March 31, 2026. Available from: https://www.aamc.org/media/75236/download

Ref. 697. Karanth SD, et al. (2026) Cancers (Basel), 18. Available from: https://doi.org/10.3390/cancers18040601

Ref. 698. Doshi RH, et al. (2026) Public Health, 252: 106091. Available from: https://doi.org/10.1016/j.puhe.2025.106091

Ref. 699. Emile SH, et al. (2025) Am Surg, 91: 528. Available from: https://doi.org/10.1177/00031348241304013

Ref. 700. Martinez AE, et al. (2026) Ann Surg Oncol. Available from: https://doi.org/10.1245/s10434-026-19483-7

Ref. 701. Hamdy FC, et al. (2023) N Engl J Med, 388: 1547. Available from: https://doi.org/10.1056/NEJMoa2214122

Ref. 702. Newcomb LF, et al. (2024) JAMA, 331: 2084. Available from: https://doi.org/10.1001/jama.2024.6695

Ref. 703. Finocchiaro A, et al. (2025) J Racial Ethn Health Disparities. Available from: https://doi.org/10.1007/s40615-025-02497-4

Ref. 704. Holland MM, et al. (2025) J Gastrointest Surg, 29: 102037. Available from: https://doi.org/10.1016/j.gassur.2025.102037

Ref. 705. Broekhuis JM, et al. (2023) JAMA Surg, 158: 111. Available from: https://doi.org/10.1001/jamasurg.2022.3950

Ref. 706. Webber AA, et al. (2025) Curr Probl Surg, 63: 101697. Available from: https://doi.org/10.1016/j.cpsurg.2024.101697

Ref. 707. Abdel-Wahab M, et al. (2024) Lancet Oncol, 25: e545. Available from: https://doi.org/10.1016/S1470-2045(24)00407-8

Ref. 708. Wang K, et al. (2021) CA Cancer J Clin, 71: 437. Available from: https://doi.org/10.3322/caac.21689

Ref. 709. Kishan AU, et al. (2025) Clin Cancer Res, 31: 2530. Available from: https://doi.org/10.1158/1078-0432.CCR-24-3951

Ref. 710. Meattini I, et al. (2025) JAMA Oncol, 11: 329. Available from: https://doi.org/10.1001/jamaoncol.2024.5780

Ref. 711. American Association for Cancer Research. AACR Cancer Progress Report 2018. Accessed: March 31, 2026. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2020/09/AACR_CPR_2018.pdf

Ref. 712. American Association for Cancer Research. AACR Cancer Progress Report 2021. Accessed: March 31, 2026. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2021/10/AACR_CPR_2021.pdf

Ref. 713. Giugliano F, et al. (2025) Cancer Treat Rev, 136: 102940. Available from: https://doi.org/10.1016/j.ctrv.2025.102940

Ref. 714. Davis RA, et al. (2023) J Med Chem, 66: 9842. Available from: https://doi.org/10.1021/acs.jmedchem.3c00631

Ref. 715. Ganguly T, et al. (2023) J Nucl Med, 64: 639. Available from: https://doi.org/10.2967/jnumed.122.264749

Ref. 716. American Association for Cancer Research. AACR Cancer Progress Report 2024. Accessed: June 11, 2025. Available from: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2024/09/AACR_CPR_2024.pdf

Ref. 717. Shrestha P, et al. (2025) JAMA Netw Open, 8: e251061. Available from: https://doi.org/10.1001/jamanetworkopen.2025.1061

Ref. 718. Reyes N, et al. (2026) Breast J, 2026: 9942451. Available from: https://doi.org/10.1155/tbj/9942451

Ref. 719. Washington CG, et al. (2024) Cancers (Basel), 16. Available from: https://doi.org/10.3390/cancers16223837

Ref. 720. Courtney PT, et al. (2026) Front Oncol, 16: 1694910. Available from: https://doi.org/10.3389/fonc.2026.1694910

Ref. 721. Grobman B, et al. (2026) JNCI: Journal of the National Cancer Institute. Available from: https://doi.org/10.1093/jnci/djag098

Ref. 722. Cho WK, et al. (2024) JAMA Oncol, 10: 737. Available from: https://doi.org/10.1001/jamaoncol.2024.0565

Ref. 723. Lee SF, et al. (2024) BMJ, 386: e079089. Available from: https://doi.org/10.1136/bmj-2023-079089

Ref. 724. Booth S, et al. (2024) Pract Radiat Oncol, 14: e305. Available from: https://doi.org/10.1016/j.prro.2024.04.010

Ref. 725. Olomu MUO, et al. (2025) Breast Cancer Res Treat, 215: 47. Available from: https://doi.org/10.1007/s10549-025-07871-8

Ref. 726. Freeman JQ, et al. (2025) JAMA Netw Open, 8: e2549109. Available from: https://doi.org/10.1001/jamanetworkopen.2025.49109

Ref. 727. Jackson I, et al. (2025) NPJ Breast Cancer, 11: 138. Available from: https://doi.org/10.1038/s41523-025-00854-4

Ref. 728. Jackson I, et al. (2025) JCO Oncol Pract, 21: 1618. Available from: https://doi.org/10.1200/OP-24-00871

Ref. 729. Grewal M, et al. (2025) World J Surg, 49: 262. Available from: https://doi.org/10.1002/wjs.12431

Ref. 730. Ho KL, et al. (2026) J Racial Ethn Health Disparities. Available from: https://doi.org/10.1007/s40615-025-02801-2

Ref. 731. Obeng-Gyasi S, et al. (2026) Cancer Epidemiol Biomarkers Prev, 35: 128. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0986

Ref. 732. White C, et al. (2021) Pharmgenomics Pers Med, 14: 1603. Available from: https://doi.org/10.2147/PGPM.S337147

Ref. 733. Chan TH, et al. (2024) Br J Cancer, 131: 498. Available from: https://doi.org/10.1038/s41416-024-02754-z

Ref. 734. Hiam-Galvez KJ, et al. (2021) Nat Rev Cancer, 21: 345. Available from: https://doi.org/10.1038/s41568-021-00347-z

Ref. 735. Mishra AK, et al. (2022) Diseases, 10. Available from: https://doi.org/10.3390/diseases10030060

Ref. 736. Kaufmann SHE (2019) Front Immunol, 10: 684. Available from: https://doi.org/10.3389/fimmu.2019.00684

Ref. 737. Podany EL, et al. (2025) JAMA Netw Open, 8: e2461899. Available from: https://doi.org/10.1001/jamanetworkopen.2024.61899

Ref. 738. Valle LF, et al. (2025) JAMA Netw Open, 8: e259119. Available from: https://doi.org/10.1001/jamanetworkopen.2025.9119

Ref. 739. Rae S, et al. (2026) Cancer Med, 15: e71668. Available from: https://doi.org/10.1002/cam4.71668

Ref. 740. Kiel PJ, et al. (2026) Clin Med Insights Oncol, 20: 11795549261417371. Available from: https://doi.org/10.1177/11795549261417371

Ref. 741. Korn SM, et al. (2025) JNCI Cancer Spectr, 9. Available from: https://doi.org/10.1093/jncics/pkaf051

Ref. 742. Dutta R, et al. (2023) Nat Cancer, 4: 787. Available from: https://doi.org/10.1038/s43018-023-00568-1

Ref. 743. Vidal GA, et al. (2026) Cancer Epidemiol Biomarkers Prev. Available from: https://doi.org/10.1158/1055-9965.EPI-25-1459

Ref. 744. Chan K, et al. (2025) JAMA Oncol, 11: 786. Available from: https://doi.org/10.1001/jamaoncol.2025.1138

Ref. 745. Hage Chehade C, et al. (2024) JAMA Netw Open, 7: e2423186. Available from: https://doi.org/10.1001/jamanetworkopen.2024.23186

Ref. 746. Diaz GM, et al. (2025) Urology. Available from: https://doi.org/10.1016/j.urology.2025.12.004

Ref. 747. Ostrowski M, et al. (2025) JAMA Netw Open, 8: e2534968. Available from: https://doi.org/10.1001/jamanetworkopen.2025.34968

Ref. 748. Kiel PJ, et al. (2025) J Cancer Educ. Available from: https://doi.org/10.1007/s13187-025-02775-z

Ref. 749. Carroway WP, et al. (2025) Front Surg, 12: 1632360. Available from: https://doi.org/10.3389/fsurg.2025.1632360

Ref. 750. Lee M, et al. (2026) NPJ Precis Oncol, 10. Available from: https://doi.org/10.1038/s41698-025-01259-z

Ref. 751. Garon EB, et al. (2019) J Clin Oncol, 37: 2518. Available from: https://doi.org/10.1200/JCO.19.00934

Ref. 752. Wolchok JD, et al. (2025) N Engl J Med, 392: 11. Available from: https://doi.org/10.1056/NEJMoa2407417

Ref. 753. Ali MS, et al. (2025) Immunotherapy, 17: 37. Available from: https://doi.org/10.1080/1750743X.2025.2452836

Ref. 754. Zhao J, et al. (2025) JAMA Netw Open, 8: e2519274. Available from: https://doi.org/10.1001/jamanetworkopen.2025.19274

Ref. 755. Freeman JQ, et al. (2025) JAMA Netw Open, 8: e2460243. Available from: https://doi.org/10.1001/jamanetworkopen.2024.60243

Ref. 756. Miller S, et al. (2024) Lancet Oncol, 25: 1666. Available from: https://doi.org/10.1016/S1470-2045(24)00528-X

Ref. 757. Dana H, et al. (2021) Acta Pharm Sin B, 11: 1129. Available from: https://doi.org/10.1016/j.apsb.2020.10.020

Ref. 758. Brudno JN, et al. (2024) JAMA, 332: 1924. Available from: https://doi.org/10.1001/jama.2024.19462

Ref. 759. Chung AP, et al. (2025) Blood Adv, 9: 4727. Available from: https://doi.org/10.1182/bloodadvances.2024015634

Ref. 760. Karmali R, et al. (2024) Blood Adv, 8: 2592. Available from: https://doi.org/10.1182/bloodadvances.2023011996

Ref. 761. Valtis YK, et al. (2025) JAMA Oncol, 11: 781. Available from: https://doi.org/10.1001/jamaoncol.2025.1127

Ref. 762. Jagannath S, et al. (2025) J Clin Oncol, 43: 2766. Available from: https://doi.org/10.1200/JCO-25-00760

Ref. 763. Davidson J, et al. (2026) Cancers (Basel), 18. Available from: https://doi.org/10.3390/cancers18040669

Ref. 764. Kaparis S, et al. (2025) Blood Rev: 101358. Available from: https://doi.org/10.1016/j.blre.2025.101358

Ref. 765. Munshi PN, et al. (2026) Transplant Cell Ther. Available from: https://doi.org/10.1016/j.jtct.2026.02.001

Ref. 766. Byrne MT, et al. (2025) JAMA Oncol, 11: 481. Available from: https://doi.org/10.1001/jamaoncol.2025.0042

Ref. 767. US Food & Drug Administration. FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies. Accessed: March 31, 2026. Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor

Ref. 768. Espinoza-Gutarra MR, et al. (2026) Blood Lymphat Cancer, 16: 559759. Available from: https://doi.org/10.2147/BLCTT.S559759

Ref. 769. Kim RB, et al. (2025) J Racial Ethn Health Disparities, 12: 2646. Available from: https://doi.org/10.1007/s40615-024-02077-y

Ref. 770. Heath E, et al. (2024) Cancer Res Commun, 4: 2598. Available from: https://doi.org/10.1158/2767-9764.CRC-24-0321

Ref. 771. Dong J, et al. (2022) Blood Cancer J, 12: 34. Available from: https://doi.org/10.1038/s41408-022-00633-5

Ref. 772. Wang X, et al. (2025) Blood Adv, 9: 533. Available from: https://doi.org/10.1182/bloodadvances.2024014127

Ref. 773. Chan RJ, et al. (2023) CA Cancer J Clin, 73: 565. Available from: https://doi.org/10.3322/caac.21788

Ref. 774. Chen M, et al. (2024) Curr Oncol Rep, 26: 504. Available from: https://doi.org/10.1007/s11912-024-01514-9

Ref. 775. McClelland S, 3rd, et al. (2026) Am J Clin Oncol, 49: 125. Available from: https://doi.org/10.1097/COC.0000000000001257

Ref. 776. Allen AJ, et al. (2026) JCO Oncol Pract: OP2500983. Available from: https://doi.org/10.1200/OP-25-00983

Ref. 777. Graboyes EM, et al. (2025) JCO Oncol Pract, 21: 1153. Available from: https://doi.org/10.1200/OP-24-00901

Ref. 778. Gany F, et al. (2025) J Natl Compr Canc Netw, 23. Available from: https://doi.org/10.6004/jnccn.2025.7017

Ref. 779. Wood EH, et al. (2026) Cancers, 18: 1247

Ref. 780. Thomas M, et al. (2025) JCO Oncol Pract: OP2500531. Available from: https://doi.org/10.1200/OP-25-00531

Ref. 781. Patel MI, et al. (2026) JAMA, 335: 674. Available from: https://doi.org/10.1001/jama.2025.23403

Ref. 782. Hooda Z, et al. (2025) Ann Thorac Surg, 120: 401. Available from: https://doi.org/10.1016/j.athoracsur.2025.03.042

Ref. 783. Lyons JM, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17020207

Ref. 784. Hohenleitner JT, et al. (2026) JAMA Surg. Available from: https://doi.org/10.1001/jamasurg.2026.0057

Ref. 785. Krishnamurthy S, et al. (2025) JAMA Netw Open, 8: e258086. Available from: https://doi.org/10.1001/jamanetworkopen.2025.8086

Ref. 786. Torrado C, et al. (2026) Oncologist, 31. Available from: https://doi.org/10.1093/oncolo/oyag075

Ref. 787. Levine DM, et al. (2025) JAMA Netw Open, 8: e2545712. Available from: https://doi.org/10.1001/jamanetworkopen.2025.45712

Ref. 788. Egger ME, et al. (2026) J Am Coll Surg, 242: 1032. Available from: https://doi.org/10.1097/XCS.0000000000001781

Ref. 789. Mollica MA, et al. (2025) Cancer, 131: e70039. Available from: https://doi.org/10.1002/cncr.70039

Ref. 790. Hassan AM, et al. (2025) Breast Cancer Res Treat, 215: 1. Available from: https://doi.org/10.1007/s10549-025-07829-w

Ref. 791. Yarosh RA, et al. (2025) Cancer, 131: e35650. Available from: https://doi.org/10.1002/cncr.35650

Ref. 792. Brandt C, et al. (2024) Int J Cancer, 155: 996. Available from: https://doi.org/10.1002/ijc.34971

Ref. 793. Diaz AE, et al. (2026) JNCI Cancer Spectr, 10. Available from: https://doi.org/10.1093/jncics/pkaf117

Ref. 794. Ho K, et al. (2025) Cancer Causes Control, 36: 1813. Available from: https://doi.org/10.1007/s10552-025-02054-8

Ref. 795. Zhang L, et al. (2025) J Am Heart Assoc, 14: e037780. Available from: https://doi.org/10.1161/JAHA.124.037780

Ref. 796. Schneider BP, et al. (2015) Clin Cancer Res, 21: 5082. Available from: https://doi.org/10.1158/1078-0432.CCR-15-0586

Ref. 797. Joshy G, et al. (2023) BMC Cancer, 23: 774. Available from: https://doi.org/10.1186/s12885-023-11214-5

Ref. 798. Zhang Y, et al. (2025) BMC Public Health, 25: 325. Available from: https://doi.org/10.1186/s12889-025-21406-2

Ref. 799. Choi H, et al. (2025) JAMA Netw Open, 8: e2549972. Available from: https://doi.org/10.1001/jamanetworkopen.2025.49972

Ref. 800. Bhattacharyya O, et al. (2026) Cancer Med, 15: e71536. Available from: https://doi.org/10.1002/cam4.71536

Ref. 801. Brown JC, et al. (2025) JNCI Cancer Spectr, 9. Available from: https://doi.org/10.1093/jncics/pkaf084

Ref. 802. Cao C, et al. (2024) J Clin Oncol, 42: 2257. Available from: https://doi.org/10.1200/JCO.23.02536

Ref. 803. Waters AR, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1405. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0166

Ref. 804. Li Q, et al. (2025) EClinicalMedicine, 84: 103274. Available from: https://doi.org/10.1016/j.eclinm.2025.103274

Ref. 805. Strongman H, et al. (2022) JACC CardioOncol, 4: 113. Available from: https://doi.org/10.1016/j.jaccao.2022.01.102

Ref. 806. Cheville AL, et al. (2025) BMJ, 390. Available from: https://doi.org/10.1136/bmj-2024-081351

Ref. 807. Obeng-Gyasi B, et al. (2025) Support Care Cancer, 33: 311. Available from: https://doi.org/10.1007/s00520-025-09362-4

Ref. 808. Karschnia P, et al. (2025) Nat Rev Cancer, 25: 887. Available from: https://doi.org/10.1038/s41568-025-00863-2

Ref. 809. Schneider BP, et al. (2024) J Clin Oncol, 42: 2899. Available from: https://doi.org/10.1200/JCO.24.00526

Ref. 810. Nguyen-Hoang N, et al. (2025) Crit Rev Oncol Hematol, 211: 104739. Available from: https://doi.org/10.1016/j.critrevonc.2025.104739

Ref. 811. Shao L, et al. (2025) J Natl Cancer Inst. Available from: https://doi.org/10.1093/jnci/djaf372

Ref. 812. Cheng HG, et al. (2026) Cancer Epidemiol Biomarkers Prev, 35: 165. Available from: https://doi.org/10.1158/1055-9965.EPI-25-1197

Ref. 813. Forbes H, et al. (2024) EClinicalMedicine, 76: 102826. Available from: https://doi.org/10.1016/j.eclinm.2024.102826

Ref. 814. Kittel JA, et al. (2025) J Affect Disord, 390: 119813. Available from: https://doi.org/10.1016/j.jad.2025.119813

Ref. 815. Springer F, et al. (2025) Psychooncology, 34: e70059. Available from: https://doi.org/10.1002/pon.70059

Ref. 816. Balogun Z, et al. (2024) JAMA Otolaryngol Head Neck Surg, 150: 295. Available from: https://doi.org/10.1001/jamaoto.2023.4672

Ref. 817. Zhong M, et al. (2026) Eur J Oncol Nurs, 80: 103103. Available from: https://doi.org/10.1016/j.ejon.2026.103103

Ref. 818. Robinson JRM, et al. (2025) J Cancer Surviv, 19: 356. Available from: https://doi.org/10.1007/s11764-023-01471-5

Ref. 819. Giblon R, et al. (2025) Psychooncology, 34: e70199. Available from: https://doi.org/10.1002/pon.70199

Ref. 820. Mevawalla A, et al. (2026) J Cancer Surviv. Available from: https://doi.org/10.1007/s11764-026-01981-y

Ref. 821. Mahoney DE, et al. (2024) Gynecol Oncol, 189: 24. Available from: https://doi.org/10.1016/j.ygyno.2024.06.027

Ref. 822. Yoon PS, et al. (2024) Qual Life Res, 33: 793. Available from: https://doi.org/10.1007/s11136-023-03566-z

Ref. 823. Gallagher TJ, et al. (2025) Head Neck, 47: 1885. Available from: https://doi.org/10.1002/hed.28103

Ref. 824. Miro-Rivera D, et al. (2025) JAMA Netw Open, 8: e2527585. Available from: https://doi.org/10.1001/jamanetworkopen.2025.27585

Ref. 825. Arizpe A, et al. (2025) J Racial Ethn Health Disparities, 12: 1765. Available from: https://doi.org/10.1007/s40615-024-02006-z

Ref. 826. Franco-Rocha OY, et al. (2025) Psychooncology, 34: e70154. Available from: https://doi.org/10.1002/pon.70154

Ref. 827. Karvonen KA, et al. (2023) Cancer, 129: 3023. Available from: https://doi.org/10.1002/cncr.34913

Ref. 828. Brown JA, et al. (2024) J Natl Cancer Inst, 116: 1845. Available from: https://doi.org/10.1093/jnci/djae154

Ref. 829. Garrett E, et al. (2024) J Natl Cancer Inst, 116: 258. Available from: https://doi.org/10.1093/jnci/djad208

Ref. 830. Boehmer U, et al. (2022) Cancer, 128: 284. Available from: https://doi.org/10.1002/cncr.33915

Ref. 831. Kitaw TA, et al. (2025) BMJ Glob Health, 10. Available from: https://doi.org/10.1136/bmjgh-2024-017133

Ref. 832. Mollica MA, et al. (2024) Support Care Cancer, 32: 137. Available from: https://doi.org/10.1007/s00520-024-08328-2

Ref. 833. Yabroff KR, et al. (2024) CA Cancer J Clin, 74: 341. Available from: https://doi.org/10.3322/caac.21837

Ref. 834. Anant S, et al. (2025) JCO Oncol Pract, 21: 41. Available from: https://doi.org/10.1200/OP.24.00305

Ref. 835. Myers S, et al. (2025) Support Care Cancer, 33: 339. Available from: https://doi.org/10.1007/s00520-025-09393-x

Ref. 836. Pak TY (2025) Health Econ Rev, 15: 22. Available from: https://doi.org/10.1186/s13561-025-00596-w

Ref. 837. Hammarlund N, et al. (2025) J Cancer Surviv. Available from: https://doi.org/10.1007/s11764-025-01817-1

Ref. 838. Gu C, et al. (2024) J Cancer Surviv, 18: 385. Available from: https://doi.org/10.1007/s11764-022-01201-3

Ref. 839. Cai J, et al. (2025) Ann Surg, 282: 658. Available from: https://doi.org/10.1097/SLA.0000000000006908

Ref. 840. Anderson-Buettner AS, et al. (2024) BMC Health Serv Res, 24: 928. Available from: https://doi.org/10.1186/s12913-024-11357-6

Ref. 841. Wang S, et al. (2024) JAMA Oncol. Available from: https://doi.org/10.1001/jamaoncol.2024.5016

Ref. 842. Garg S, et al. (2025) Support Care Cancer, 33: 91. Available from: https://doi.org/10.1007/s00520-024-09130-w

Ref. 843. Dhir A, et al. (2024) JAMA Netw Open, 7: e2429286. Available from: https://doi.org/10.1001/jamanetworkopen.2024.29286

Ref. 844. Deng YF, et al. (2025) J Psychosoc Oncol: 1. Available from: https://doi.org/10.1080/07347332.2025.2596065

Ref. 845. Waters AR, et al. (2025) Cancer Control, 32: 10732748251351105. Available from: https://doi.org/10.1177/10732748251351105

Ref. 846. Bluethmann SM, et al. (2016) Cancer Epidemiol Biomarkers Prev, 25: 1029. Available from: https://doi.org/10.1158/1055-9965.EPI-16-0133

Ref. 847. Miller KD, et al. (2022) CA Cancer J Clin, 72: 409. Available from: https://doi.org/10.3322/caac.21731

Ref. 848. Chen W, et al. (2024) J Natl Cancer Inst, 116: 1730. Available from: https://doi.org/10.1093/jnci/djae163

Ref. 849. Rees-Punia E, et al. (2024) Cancer, 130: 312. Available from: https://doi.org/10.1002/cncr.35047

Ref. 850. Williams GR, et al. (2018) Oncologist, 23: 433. Available from: https://doi.org/10.1634/theoncologist.2017-0404

Ref. 851. Singla C, et al. (2026) Clinical Oncology: 104097. Available from: https://doi.org/10.1016/j.clon.2026.104097

Ref. 852. Duchesneau ED, et al. (2025) JAMA Netw Open, 8: e250614. Available from: https://doi.org/10.1001/jamanetworkopen.2025.0614

Ref. 853. Lee HN, et al. (2025) J Geriatr Oncol, 16: 102277. Available from: https://doi.org/10.1016/j.jgo.2025.102277

Ref. 854. Sedrak MS, et al. (2024) J Cancer Surviv, 18: 1131. Available from: https://doi.org/10.1007/s11764-024-01594-3

Ref. 855. Masnoon N, et al. (2017) BMC Geriatr, 17: 230. Available from: https://doi.org/10.1186/s12877-017-0621-2

Ref. 856. La J, et al. (2025) J Natl Compr Canc Netw, 23: 363. Available from: https://doi.org/10.6004/jnccn.2025.7051

Ref. 857. Mohamed MR, et al. (2024) Support Care Cancer, 32: 674. Available from: https://doi.org/10.1007/s00520-024-08877-6

Ref. 858. Taylor M, et al. (2025) JAMA Netw Open, 8: e2544812. Available from: https://doi.org/10.1001/jamanetworkopen.2025.44812

Ref. 859. Birch K, et al. (2023) JCO Oncol Pract, 19: e660. Available from: https://doi.org/10.1200/OP.22.00555

Ref. 860. Pilleron S, et al. (2023) J Geriatr Oncol, 14: 101519. Available from: https://doi.org/10.1016/j.jgo.2023.101519

Ref. 861. Zhao J, et al. (2024) J Natl Compr Canc Netw, 22: 244. Available from: https://doi.org/10.6004/jnccn.2023.7114

Ref. 862. Davis ES, et al. (2024) Cancer, 130: 3487. Available from: https://doi.org/10.1002/cncr.35437

Ref. 863. Owsley KM, et al. (2025) J Cancer Surviv. Available from: https://doi.org/10.1007/s11764-025-01797-2

Ref. 864. Dotan E, et al. (2024) Cancer Med, 13: e6790. Available from: https://doi.org/10.1002/cam4.6790

Ref. 865. Loh KP, et al. (2024) ESMO Open, 9: 103657. Available from: https://doi.org/10.1016/j.esmoop.2024.103657

Ref. 866. Magnuson A, et al. (2024) CA Cancer J Clin, 74: 496. Available from: https://doi.org/10.3322/caac.21864

Ref. 867. Liu K, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 998. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0037

Ref. 868. Chang CY, et al. (2023) J Manag Care Spec Pharm, 29: 431. Available from: https://doi.org/10.18553/jmcp.2023.29.4.431

Ref. 869. Chang CP, et al. (2025) J Rural Health, 41: e70029. Available from: https://doi.org/10.1111/jrh.70029

Ref. 870. NCCR*Explorer: An interactive website for NCCR cancer statistics [Internet]. National Cancer Institute; 2025 Sep 24. [updated: 2026 Apr 30; cited 2026 May 11]. Available from: https://nccrexplorer.ccdi.cancer.gov

Ref. 871. Page LL, et al. (2025) J Natl Cancer Inst, 117: 529. Available from: https://doi.org/10.1093/jnci/djae250

Ref. 872. Freyer DR, et al. (2026) J Cancer Surviv. Available from: https://doi.org/10.1007/s11764-026-01986-7

Ref. 873. Bhatia S, et al. (2023) JAMA, 330: 1175. Available from: https://doi.org/10.1001/jama.2023.16875

Ref. 874. Hudson MM, et al. (2021) Pediatrics, 148. Available from: https://doi.org/10.1542/peds.2021-053127

Ref. 875. Roganovic J (2025) World J Clin Cases, 13: 98000. Available from: https://doi.org/10.12998/wjcc.v13.i7.98000

Ref. 876. Bhandari R, et al. (2025) J Clin Oncol, 43: 2998. Available from: https://doi.org/10.1200/JCO-25-00385

Ref. 877. Guida JL, et al. (2024) Nat Cancer, 5: 731. Available from: https://doi.org/10.1038/s43018-024-00745-w

Ref. 878. Yeh JM, et al. (2025) JAMA Oncol, 11: 535. Available from: https://doi.org/10.1001/jamaoncol.2025.0236

Ref. 879. Alliance for Fertility Preservation. State Laws & Legislation. Accessed: April 3, 2026. Available from: https://www.allianceforfertilitypreservation.org/expenses/laws-legislation/

Ref. 880. Pizzo A, et al. (2024) JAMA Netw Open, 7: e2436144. Available from: https://doi.org/10.1001/jamanetworkopen.2024.36144

Ref. 881. Zhang A, et al. (2025) JAMA Netw Open, 8: e2511430. Available from: https://doi.org/10.1001/jamanetworkopen.2025.11430

Ref. 882. McGrady ME, et al. (2024) J Clin Oncol, 42: 707. Available from: https://doi.org/10.1200/JCO.23.01465

Ref. 883. Yang M, et al. (2026) Qual Life Res, 35: 75. Available from: https://doi.org/10.1007/s11136-026-04181-4

Ref. 884. Hernadfoi MV, et al. (2024) JAMA Pediatr, 178: 548. Available from: https://doi.org/10.1001/jamapediatrics.2024.0642

Ref. 885. Kim Y, et al. (2025) Pediatr Blood Cancer, 72: e31980. Available from: https://doi.org/10.1002/pbc.31980

Ref. 886. Kirchhoff AC, et al. (2024) J Natl Cancer Inst, 116: 1466. Available from: https://doi.org/10.1093/jnci/djae111

Ref. 887. Kirchhoff AC, et al. (2024) J Clin Oncol, 42: 642. Available from: https://doi.org/10.1200/JCO.23.01027

Ref. 888. Khurana RK, et al. (2025) Cancer Control, 32: 10732748251409888. Available from: https://doi.org/10.1177/10732748251409888

Ref. 889. Berkman AM, et al. (2024) J Natl Cancer Inst, 116: 1417. Available from: https://doi.org/10.1093/jnci/djae119

Ref. 890. Ehrhardt MJ, et al. (2024) J Clin Oncol, 42: 743. Available from: https://doi.org/10.1200/JCO.23.01504

Ref. 891. Wong CL, et al. (2024) BMJ Open, 14: e087343. Available from: https://doi.org/10.1136/bmjopen-2024-087343

Ref. 892. DeVine A, et al. (2025) JAMA Oncol, 11: 544. Available from: https://doi.org/10.1001/jamaoncol.2024.6812

Ref. 893. Milam J, et al. (2024) Pediatr Blood Cancer, 71: e31328. Available from: https://doi.org/10.1002/pbc.31328

Ref. 894. Wilsnack C, et al. (2026) J Cancer Surviv, 20: 336. Available from: https://doi.org/10.1007/s11764-024-01707-y

Ref. 895. Chen C, et al. (2024) JAMA Netw Open, 7: e2419771. Available from: https://doi.org/10.1001/jamanetworkopen.2024.19771

Ref. 896. Noyd DH, et al. (2025) J Adolesc Young Adult Oncol, 14: 516. Available from: https://doi.org/10.1089/jayao.2024.0151

Ref. 897. Rodriguez-Ormaza N, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1194. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0482

Ref. 898. Choi E, et al. (2024) Support Care Cancer, 32: 585. Available from: https://doi.org/10.1007/s00520-024-08778-8

Ref. 899. Robles JM, et al. (2025) JCO Oncol Pract: OP2500389. Available from: https://doi.org/10.1200/OP-25-00389

Ref. 900. Cannavale KL, et al. (2025) J Cancer Surviv, 19: 1806. Available from: https://doi.org/10.1007/s11764-024-01596-1

Ref. 901. Strange LF, et al. (2025) Cancer Epidemiol Biomarkers Prev, 34: 1332. Available from: https://doi.org/10.1158/1055-9965.EPI-25-0023

Ref. 902. Caturegli G, et al. (2025) JAMA Oncol, 11: 564. Available from: https://doi.org/10.1001/jamaoncol.2025.0247

Ref. 903. Wojcik KM, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 1610. Available from: https://doi.org/10.1158/1055-9965.EPI-24-0650

Ref. 904. Zamora AN, et al. (2025) BMC Public Health, 25: 737. Available from: https://doi.org/10.1186/s12889-025-21885-3

Ref. 905. Burse NR, et al. (2026) J Racial Ethn Health Disparities, 13: 916. Available from: https://doi.org/10.1007/s40615-025-02303-1

Ref. 906. Robertson T, et al. (2025) Cancer Causes Control, 36: 1869. Available from: https://doi.org/10.1007/s10552-025-02065-5

Ref. 907. Lin JC, et al. (2025) JAMA Health Forum, 6: e251381. Available from: https://doi.org/10.1001/jamahealthforum.2025.1381

Ref. 908. Patel KB, et al. (2024) Gynecol Oncol, 188: 8. Available from: https://doi.org/10.1016/j.ygyno.2024.05.029

Ref. 909. Lee CY, et al. (2025) J Cancer Surviv, 19: 1861. Available from: https://doi.org/10.1007/s11764-024-01600-8

Ref. 910. Mama SK, et al. (2024) J Natl Cancer Inst, 116: 1333. Available from: https://doi.org/10.1093/jnci/djae097

Ref. 911. Marker RJ, et al. (2025) JMIR Cancer, 11: e59478. Available from: https://doi.org/10.2196/59478

Ref. 912. Aziz-Bose R, et al. (2025) J Cancer Surviv. Available from: https://doi.org/10.1007/s11764-024-01733-w

Ref. 913. Tohmasi S, et al. (2025) J Natl Compr Canc Netw, 23. Available from: https://doi.org/10.6004/jnccn.2025.7059

Ref. 914. Cinciripini PM, et al. (2024) JAMA Oncol, 10: 1689. Available from: https://doi.org/10.1001/jamaoncol.2024.4890

Ref. 915. Andersen BL, et al. (2023) J Clin Oncol, 41: 3426. Available from: https://doi.org/10.1200/JCO.23.00293

Ref. 916. Li M, et al. (2017) Psychooncology, 26: 573. Available from: https://doi.org/10.1002/pon.4286

Ref. 917. Irwin KE, et al. (2022) Contemp Clin Trials, 123: 106975. Available from: https://doi.org/10.1016/j.cct.2022.106975

Ref. 918. Steel JL, et al. (2024) Lancet, 403: 1351. Available from: https://doi.org/10.1016/S0140-6736(24)00015-1

Ref. 919. Aburizik A, et al. (2023) Psychooncology, 32: 1675. Available from: https://doi.org/10.1002/pon.6217

Ref. 920. Price S, et al. (2024) J Psychosoc Oncol, 42: 90. Available from: https://doi.org/10.1080/07347332.2023.2224314

Ref. 921. Llave K, et al. (2024) Int J Behav Med, 31: 848. Available from: https://doi.org/10.1007/s12529-024-10264-8

Ref. 922. Olver I, et al. (2020) Support Care Cancer, 28: 3467. Available from: https://doi.org/10.1007/s00520-020-05447-4

Ref. 923. Sanders JJ, et al. (2024) J Clin Oncol, 42: 2336. Available from: https://doi.org/10.1200/JCO.24.00542

Ref. 924. Taylor A, et al. (2025) Clin Med (Lond), 25: 100487. Available from: https://doi.org/10.1016/j.clinme.2025.100487

Ref. 925. Hart NH, et al. (2024) JCO Oncol Pract, 20: 1160. Available from: https://doi.org/10.1200/OP.23.00716

Ref. 926. Petrillo LA, et al. (2024) Am Soc Clin Oncol Educ Book, 44: e100038. Available from: https://doi.org/10.1200/EDBK_100038

Ref. 927. Freeman JQ, et al. (2024) J Rural Health, 40: 602. Available from: https://doi.org/10.1111/jrh.12826

Ref. 928. Iqbal J, et al. (2024) JAMA Netw Open, 7: e240503. Available from: https://doi.org/10.1001/jamanetworkopen.2024.0503

Ref. 929. Osakwe ZT, et al. (2024) Am J Hosp Palliat Care, 41: 309. Available from: https://doi.org/10.1177/10499091231195319

Ref. 930. Ramkumar N, et al. (2023) J Rural Health, 39: 557. Available from: https://doi.org/10.1111/jrh.12739

Ref. 931. Whitman J, et al. (2026) Am J Hosp Palliat Care: 10499091261425959. Available from: https://doi.org/10.1177/10499091261425959

Ref. 932. Freeman JQ, et al. (2024) J Palliat Med, 27: 763. Available from: https://doi.org/10.1089/jpm.2023.0547

Ref. 933. Khayal IS, et al. (2025) Lancet Reg Health Am, 47: 101135. Available from: https://doi.org/10.1016/j.lana.2025.101135

Ref. 934. Kohli K, et al. (2024) Support Care Cancer, 32: 494. Available from: https://doi.org/10.1007/s00520-024-08633-w

Ref. 935. Currow DC, et al. (2020) J Clin Oncol, 38: 937. Available from: https://doi.org/10.1200/JCO.18.02235

Ref. 936. Abdallah M, et al. (2024) J Geriatr Oncol, 15: 101810. Available from: https://doi.org/10.1016/j.jgo.2024.101810

Ref. 937. Bazargan M, et al. (2021) Am J Hosp Palliat Care, 38: 688. Available from: https://doi.org/10.1177/1049909120966585

Ref. 938. Jawed A, et al. (2024) Ann Palliat Med, 13: 309. Available from: https://doi.org/10.21037/apm-23-459

Ref. 939. Lenko RA, et al. (2024) J Am Geriatr Soc, 72: 2412. Available from: https://doi.org/10.1111/jgs.18971

Ref. 940. Yan C, et al. (2026) JAMA Netw Open, 9: e2554797. Available from: https://doi.org/10.1001/jamanetworkopen.2025.54797

Ref. 941. Carter B, et al. (2026) J Gen Intern Med. Available from: https://doi.org/10.1007/s11606-026-10231-x

Ref. 942. Weiss M, et al. (2025) Am Soc Clin Oncol Educ Book, 45: e472842. Available from: https://doi.org/10.1200/EDBK-25-472842

Ref. 943. Fariman S, et al. (2026) Am J Hosp Palliat Care: 10499091251414863. Available from: https://doi.org/10.1177/10499091251414863

Ref. 944. Cole AP, et al. (2019) JAMA Netw Open, 2: e187633. Available from: https://doi.org/10.1001/jamanetworkopen.2018.7633

Ref. 945. Greer JA, et al. (2024) JAMA, 332: 1153. Available from: https://doi.org/10.1001/jama.2024.13964

Ref. 946. Parikh RB, et al. (2025) JAMA Netw Open, 8: e2458576. Available from: https://doi.org/10.1001/jamanetworkopen.2024.58576

Ref. 947. Volandes AE, et al. (2025) JAMA Netw Open, 8: e259150. Available from: https://doi.org/10.1001/jamanetworkopen.2025.9150

Ref. 948. Rosa WE, et al. (2025) J Pain Symptom Manage, 69: 496. Available from: https://doi.org/10.1016/j.jpainsymman.2025.02.008

Ref. 949. Patel MI, et al. (2026) JAMA, 335: 674. Available from: https://doi.org/10.1001/jama.2025.23403

Ref. 950. Patel MI, et al. (2024) J Clin Oncol, 42: 518. Available from: https://doi.org/10.1200/JCO.23.00309

Ref. 951. AARP. Caregiving in the US. Accessed: March 30, 2025. Available from: https://www.aarp.org/content/dam/aarp/ppi/topics/ltss/family-caregiving/caregiving-in-us-2025.doi.10.26419-2fppi.00373.001.pdf

Ref. 952. Fenton A, et al. (2022) Support Care Cancer, 30: 9625. Available from: https://doi.org/10.1007/s00520-022-07367-x

Ref. 953. Tan KR, et al. (2023) Curr Oncol Rep, 25: 803. Available from: https://doi.org/10.1007/s11912-023-01415-3

Ref. 954. Love B, et al. (2026) JMIR Cancer, 12: e76266. Available from: https://doi.org/10.2196/76266

Ref. 955. Allison K, et al. (2024) BMC Cancer, 24: 36. Available from: https://doi.org/10.1186/s12885-023-11732-2

Ref. 956. Waters AR, et al. (2026) Psychooncology, 35: e70379. Available from: https://doi.org/10.1002/pon.70379

Ref. 957. Wang Q, et al. (2024) J Cancer Surviv, 18: 553. Available from: https://doi.org/10.1007/s11764-022-01265-1

Ref. 958. Wang Q, et al. (2025) JCO Oncol Pract: OP2500388. Available from: https://doi.org/10.1200/OP-25-00388

Ref. 959. Badger T, et al. (2024) J Psychosoc Oncol, 42: 333. Available from: https://doi.org/10.1080/07347332.2023.2248486

Ref. 960. Oluwole SF, et al. (2003) J Am Coll Surg, 196: 180. Available from: https://doi.org/10.1016/s1072-7515(02)01765-9

Ref. 961. Causey L, et al. (2025) Clin J Oncol Nurs, 29: E60. Available from: https://doi.org/10.1188/25.CJON.E60-E69

Ref. 962. Ver Hoeve ES, et al. (2024) BMC Health Serv Res, 24: 550. Available from: https://doi.org/10.1186/s12913-024-10919-y

Ref. 963. Edward J, et al. (2024) JNCI Cancer Spectr, 8. Available from: https://doi.org/10.1093/jncics/pkae025

Ref. 964. Hong M, et al. (2024) Neurooncol Pract, 11: 575. Available from: https://doi.org/10.1093/nop/npae030

Ref. 965. Wheeler SB, et al. (2024) J Natl Compr Canc Netw, 22: 557. Available from: https://doi.org/10.6004/jnccn.2024.7030

Ref. 966. Dobbs JE, et al. (2025) JAMA Oncol, 11: 235. Available from: https://doi.org/10.1001/jamaoncol.2024.6270

Ref. 967. Daley MP, et al. (2026) Oncologist, 31. Available from: https://doi.org/10.1093/oncolo/oyaf407

Ref. 968. Warne D, et al. (2025) Front Health Serv, 5: 1469501. Available from: https://doi.org/10.3389/frhs.2025.1469501

Ref. 969. Janitz AE, et al. (2025) N Engl J Med, 393: 940. Available from: https://doi.org/10.1056/NEJMp2506273

Ref. 970. Yan AP, et al. (2020) J Clin Oncol, 38: 1711. Available from: https://doi.org/10.1200/JCO.19.01825

Ref. 971. Tarver WL, et al. (2025) J Cancer Surviv, 19: 1956. Available from: https://doi.org/10.1007/s11764-024-01609-z

Ref. 972. Ji X, et al. (2026) J Natl Cancer Inst, 118: 85. Available from: https://doi.org/10.1093/jnci/djaf276

Ref. 973. Mollica MA, et al. (2024) J Cancer Surviv, 18: 1190. Available from: https://doi.org/10.1007/s11764-024-01602-6

Ref. 974. Gupta H, et al. (2025) JAMA Netw Open, 8: e2537667. Available from: https://doi.org/10.1001/jamanetworkopen.2025.37667

Ref. 975. Alsan M, et al. (2025) J Health Econ, 100: 102968. Available from: https://doi.org/10.1016/j.jhealeco.2025.102968

Ref. 976. Fabian AJ, et al. (2026) J Racial Ethn Health Disparities, 13: 1263. Available from: https://doi.org/10.1007/s40615-025-02330-y

Ref. 977. Frakes M, et al. (2025) Rev Econ Stud. Available from: https://doi.org/10.1093/restud/rdaf072

Ref. 978. Jetty A, et al. (2022) J Racial Ethn Health Disparities, 9: 68. Available from: https://doi.org/10.1007/s40615-020-00930-4

Ref. 979. National Science Board. Talent: U.S. and Global STEM Education and Labor Force. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/pubs/nsb20243/talent-u-s-and-global-stem-education-and-labor-force

Ref. 980. National Science Foundation. Diversity and STEM. Women, Minorities, and Persons with Disabilities. 2023. Accessed: March 31, 2026. Available from: https://nsf-gov-resources.nsf.gov/doc_library/nsf23315-report.pdf

Ref. 981. Education Law Center. Making the Grade. How Fair is School Funding in Your State? Accessed: March 31, 2026. Available from: https://edlawcenter.org/wp-content/uploads/2024/12/Making-the-Grade-2024.pdf

Ref. 982. Ruth Kaggwa AB, Emma Wester, Sandra Arango-Caro, Terry Woodford-Thomas, Kristine Callis-Duehl (2023) Journal of STEM Outreach, 6: 15. Available from: https://doi.org/10.15695/jstem/v6i1.04

Ref. 983. US Government Accountability Office. Selected Federal Initiatives, Challenges, and Approaches to Supporting Rural Populations Accessed: March 31, 2026. Available from: https://www.gao.gov/assets/gao-25-107371.pdf

Ref. 984. Standford University. Federal Pandemic Relief and Academic Recovery. Accessed: March 31, 2026. Available from: https://edopportunity.org/papers/June_24_ERS_Report_20240625.pdf

Ref. 985. Case Comprehensive Cancer Center. Teach to Beat Cancer. Accessed: March 31, 2026. Available from: https://case.edu/cancer/training-education/yes/teach-beat-cancer

Ref. 986. National Institute of General Medical Sciences. Science Education Partnership Award (SEPA). Accessed: March 31, 2026. Available from: https://www.nigms.nih.gov/Research/DRCB/SEPA/Pages/default

Ref. 987. Seattle Children’s. Science Education Partnership Award Program. Accessed: March 31, 2026. Available from: https://www.seattlechildrens.org/research/centers-programs/science-education-department/science-education-partnership-award-program/

Ref. 988. National Center for Education Statistics. Table 318.45. Number and percentage distribution of science, technology, engineering, and mathematics (STEM) degrees/certificates conferred by postsecondary institutions, by race/ethnicity, level of degree/certificate, and sex of student: Academic years 2012-13 through 2021-22. Accessed: March 31, 2026. Available from: https://nces.ed.gov/programs/digest/d23/tables/dt23_318.45.asp

Ref. 989. Al Hakani MA, et al. (2024) Biochem Mol Biol Educ, 52: 527. Available from: https://doi.org/10.1002/bmb.21839

Ref. 990. Motley-Johnson E, et al. (2025) J Cancer Educ. Available from: https://doi.org/10.1007/s13187-025-02762-4

Ref. 991. Zhu L, et al. (2023) PLoS One, 18: e0286279. Available from: https://doi.org/10.1371/journal.pone.0286279

Ref. 992. Davis-Hall D, et al. (2023) Biomed Eng Educ, 3: 23. Available from: https://doi.org/10.1007/s43683-022-00096-x

Ref. 993. Kricorian K, et al. (2020) International Journal of STEM Education, 7: 16. Available from: https://doi.org/10.1186/s40594-020-00219-2

Ref. 994. National Science Foundation. Table 3. Enrollment of master’s students and doctoral students in science, engineering, and health, by field: 2018–22. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/pubs/nsf24320/table/3

Ref. 995. National Student Clearinghouse Research Center. Clearinghouse Enrollment Insights Series: Clearinghouse Final Fall Enrollment Trends. Accessed: March 31, 2026. Available from: https://nscresearchcenter.org/final-fall-enrollment-trends/

Ref. 996. National Science Foundation. Table 4-4a. Citizenship, ethnicity, and race of graduate students, by detailed field: 2023. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/pubs/nsf25317/table/4-4a

Ref. 997. National Science Foundation. Graduate students in science, engineering, and health broad fields, by degree program, citizenship, ethnicity, and race: 2024. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/surveys/graduate-students-postdoctorates-s-e/2024#tableCtr16123

Ref. 998. National Science Foundation. Citizenship of graduate students and postdoctoral appointees in science, engineering, and health: 1980–2024. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/surveys/graduate-students-postdoctorates-s-e/2024#tableCtr16118

Ref. 999. The White House. Restriction on Entry of Certain Nonimmigrant Workers. Accessed: March 31, 2026. Available from: https://www.whitehouse.gov/presidential-actions/2025/09/restriction-on-entry-of-certain-nonimmigrant-workers/

Ref. 1000. National Science Foundation. Definite non-postdoc employment commitments in industry or business in the United States, by trend broad field: 2004–24. Accessed: March 31, 2026. Available from: https://ncses.nsf.gov/pubs/nsf26315/figure/14

Ref. 1001. Swartz TH, et al. (2025) Nat Med, 31: 3590. Available from: https://doi.org/10.1038/s41591-025-03878-2

Ref. 1002. Chaudhary AMD, et al. (2021) Cureus, 13: e14930. Available from: https://doi.org/10.7759/cureus.14930

Ref. 1003. Khan S, et al. (2024) Journal of Clinical Oncology, 42: 763. Available from: https://doi.org/10.1200/JCO.2024.42.3_suppl.763

Ref. 1004. Oliveira DFM, et al. (2026) Proc Natl Acad Sci U S A, 123: e2527755123. Available from: https://doi.org/10.1073/pnas.2527755123

Ref. 1005. Science Magazine. NIH launches grant program aimed at closing the funding rate gap between Black and white investigators. Accessed: March 31, 2026. Available from: https://www.science.org/content/article/nih-launches-grant-program-aimed-closing-funding-rate-gap-between-black-and-white

Ref. 1006. Woitowich NC, et al. (2024) Elife, 12. Available from: https://doi.org/10.7554/eLife.88984

Ref. 1007. Levy MS, et al. (2025) JAMA Netw Open, 8: e252829. Available from: https://doi.org/10.1001/jamanetworkopen.2025.2829

Ref. 1008. Krischak MK, et al. (2025) Cancer, 131: e35690. Available from: https://doi.org/10.1002/cncr.35690

Ref. 1009. Li CI, et al. (2024) J Natl Cancer Inst, 116: 1198. Available from: https://doi.org/10.1093/jnci/djae100

Ref. 1010. Lerman C, et al. (2022) JNCI, 114: 1214. Available from: https://doi.org/10.1093/jnci/djac121

Ref. 1011. Owda D, et al. (2025) JAMA Netw Open, 8: e259583. Available from: https://doi.org/10.1001/jamanetworkopen.2025.9583

Ref. 1012. Witze A (2025) Nature, 640: 298. Available from: https://doi.org/10.1038/d41586-025-00938-y

Ref. 1013. Udesky L, et al. (2025) Nature. Available from: https://doi.org/10.1038/d41586-025-01216-7

Ref. 1014. Gibney E, et al. (2026) Nature. Available from: https://doi.org/10.1038/d41586-026-00405-2

Ref. 1015. STAT. STAT NIH-funded researcher survey. Accessed: March 31, 2026. Available from: https://www.documentcloud.org/documents/27888131-stat-nih-funded-researcher-survey/

Ref. 1016. Association of American Medical Colleges. 2025 FACTS: Applicants and Matriculants Data. Accessed: March 31, 2026. Available from: https://www.aamc.org/data-reports/students-residents/data/facts-applicants-and-matriculants

Ref. 1017. Association of American Medical Colleges. Report on Residents. Table B5. Number of Active MD Residents, by Race/Ethnicity (Alone or In Combination) and GME Specialty. Accessed: March 31, 2026. Available from: https://www.aamc.org/data-reports/students-residents/data/report-residents/2025/table-b5-md-residents-race-ethnicity-and-specialty

Ref. 1018. Association of American Medical Colleges. 2025 Fall Applicant, Matriculant, and Enrollment Data Tables. Accessed: March 31, 2026. Available from: https://www.aamc.org/media/87526/download?attachment

Ref. 1019. Association of American Medical Colleges. New AAMC Data on Medical School Applicants and Enrollment in 2024. Accessed: March 31, 2026. Available from: https://www.aamc.org/news/press-releases/new-aamc-data-medical-school-applicants-and-enrollment-2024

Ref. 1020. Fang P, et al. (2018) Adv Radiat Oncol, 3: 221. Available from: https://doi.org/10.1016/j.adro.2018.04.013

Ref. 1021. Ku L, et al. (2023) J Gen Intern Med, 38: 727. Available from: https://doi.org/10.1007/s11606-022-07695-y

Ref. 1022. Shen MJ, et al. (2018) J Racial Ethn Health Disparities, 5: 117. Available from: https://doi.org/10.1007/s40615-017-0350-4

Ref. 1023. Association of American Medical Colleges. U.S. Physician Workforce Data Dashboard. Accessed: March 31, 2026. Available from: https://www.aamc.org/data-reports/report/us-physician-workforce-data-dashboard

Ref. 1024. Clark L, et al. (2024) JAMA Netw Open, 7: e2446018. Available from: https://doi.org/10.1001/jamanetworkopen.2024.46018

Ref. 1025. Association of American Medical Colleges. 2025 FACTS: Enrollment, Graduates, and MD-PhD Data. Accessed: March 31, 2026. Available from: https://www.aamc.org/data-reports/students-residents/data/facts-enrollment-graduates-and-md-phd

Ref. 1026. Nguyen M, et al. (2023) JAMA Intern Med, 183: 1021. Available from: https://doi.org/10.1001/jamainternmed.2023.2822

Ref. 1027. Akabas MH, et al. (2024) JCI Insight, 9. Available from: https://doi.org/10.1172/jci.insight.178248

Ref. 1028. Jang J, et al. (2025) J Gen Intern Med, 40: 2358. Available from: https://doi.org/10.1007/s11606-025-09566-8

Ref. 1029. Mazor M, et al. (2025) Cancer, 131: e35745. Available from: https://doi.org/10.1002/cncr.35745

Ref. 1030. Tom A, et al. (2025) J Health Equity, 2. Available from: https://doi.org/10.1080/29944694.2025.2562057

Ref. 1031. Lake ET, et al. (2025) Nurs Res, 74: 405. Available from: https://doi.org/10.1097/NNR.0000000000000844

Ref. 1032. National Center for Health Workforce. State of the U.S. Health Care Workforce, 2025. Accessed: March 31, 2026. Available from: https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/State-of-US-Health-Care-Workforce-2025.pdf

Ref. 1033. Azaroff LS, et al. (2025) JAMA, 333: 2018. Available from: https://doi.org/10.1001/jama.2025.3544

Ref. 1034. National Cancer Institute. NCI Center to Reduce Cancer Health Disparities (CRCHD). Accessed: March 31, 2026. Available from: https://www.cancer.gov/about-nci/organization/crchd

Ref. 1035. National Institute of Minority Health and Health Disparities. About. Accessed: March 31, 2026. Available from: https://www.nimhd.nih.gov/about

Ref. 1036. Keck School of Medicine of USC. Researchers to utilize $7.6M and the latest technology to better understand prostate cancer predictors. Accessed: March 31, 2026. Available from: https://keck.usc.edu/news/researchers-to-utilize-7-6m-and-the-latest-technology-to-better-understand-prostate-cancer-predictors/

Ref. 1037. NIH Common Fund. Transformative Research to Address Health. Accessed: March 31, 2026. Available from: https://commonfund.nih.gov/healthdisparitiestransformation/funding-opportunities

Ref. 1038. NIH Common Fund. Community Partnerships to Advance Science for Society (ComPASS). Accessed: March 31, 2026. Available from: https://commonfund.nih.gov/compass

Ref. 1039. National Cancer Institute. Resources for Cancer Disparities Researchers. Accessed: March 31, 2026. Available from: https://www.cancer.gov/about-nci/organization/crchd/about-health-disparities/resources/cancer-disparities-resources

Ref. 1040. National Cancer Institute. National Outreach Network. Accessed: March 31, 2026. Available from: https://www.cancer.gov/about-nci/organization/crchd/community-outreach/non

Ref. 1041. National Cancer Institute. The NCI Community Oncology Research Program (NCORP). Accessed: March 31, 2026. Available from: https://ncorp.cancer.gov/

Ref. 1042. US Department of Health and Human Services. Office of Minority Health. About the Office of Minority Health. Accessed: March 31, 2026. Available from: https://minorityhealth.hhs.gov/about-office-minority-health

Ref. 1043. Healthy People 2030. Social Determinants of Health. Accessed: March 31, 2026. Available from: https://odphp.health.gov/healthypeople/priority-areas/social-determinants-health

Ref. 1044. Centers for Disease Control and Prevention. REACH 2023–2028. Accessed: March 31, 2026. Available from: https://www.cdc.gov/reach/php/reach-2023-2028/index.html

Ref. 1045. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program. Accessed: March 31, 2026. Available from: https://www.cdc.gov/breast-cervical-cancer-screening/index.html

Ref. 1046. Centers for Disease Control and Prevention. West Virginia Clinic Raises Its Colorectal Cancer Screening Rate. Accessed: March 31, 2026. Available from: https://www.cdc.gov/colorectal-cancer-control/about/west-virginia.html

Ref. 1047. Centers for Disease Control and Prevention. Using Project ECHO and Patient Navigation to Improve Care for Cancer Survivors in Rural Areas. Accessed: March 31, 2026. Available from: https://www.cdc.gov/comprehensive-cancer-control/success-stories/echo-navigation.html

Ref. 1048. Centers for Disease Control and Prevention. About the Screen for Life Campaign. Accessed: March 31, 2026. Available from: https://www.cdc.gov/colorectal-cancer/sfl/index.html

Ref. 1049. Centers for Disease Control and Prevention. About the Inside Knowledge Campaign. Accessed: March 31, 2026. Available from: https://www.cdc.gov/gynecologic-cancer/inside-knowledge/index.html

Ref. 1050. Centers for Disease Control and Prevention. About the Bring Your Brave Campaign. Accessed: March 31, 2026. Available from: https://www.cdc.gov/bring-your-brave/about/index.html

Ref. 1051. McDermott+. CMS releases 2027 policy and technical changes to Medicare Advantage and Part D proposed rule. Accessed: March 31, 2026. Available from: https://www.mcdermottplus.com/insights/cms-releases-2027-policy-and-technical-changes-to-medicare-advantage-and-part-d-proposed-rule/

Ref. 1052. Mary C (2025) Evidence-Based Oncology, 31: SP248

Ref. 1053. US Department of Health and Human Services. Fiscal Year 2026. Budget in Brief. Accessed: March 31, 2026. Available from: https://www.hhs.gov/sites/default/files/fy-2026-budget-in-brief.pdf

Ref. 1054. Kent DA, et al. (2024) J Clin Transl Sci, 8: e126. Available from: https://doi.org/10.1017/cts.2024.568

Ref. 1055. Phung L, et al. (2024) HGG Adv, 5: 100346. Available from: https://doi.org/10.1016/j.xhgg.2024.100346

Ref. 1056. Idnay B, et al. (2025) BMJ Open, 15: e107270. Available from: https://doi.org/10.1136/bmjopen-2025-107270

Ref. 1057. American Cancer Society. RFA: Cancer Health Research Centers (CHERCs). Accessed: March 31, 2026. Available from: https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/rfa-cancer-health-research-centers.html

Ref. 1058. Prevent Cancer Foundation. Cancer Prevention and Early Detection Community Grants. Accessed: March 31, 2026. Available from: https://preventcancer.org/education-outreach/community-grants/

Ref. 1059. American Association for Cancer Research. AACR Cancer Disparities Research Fellowship. Accessed: March 31, 2026. Available from: https://www.aacr.org/grants/aacr-cancer-disparities-research-fellowship-aacr-grants/

Ref. 1060. NIH RePROTER. DP21-003 NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation. Accessed: March 31, 2026. Available from: https://reporter.nih.gov/search/jedp7qSMbkOEA0CEvP2qQg/project-details/11142946

Ref. 1061. National Institutes of Health Grants & Funding. Division of Biomedical Research Workforce. Accessed: March 31, 2026. Available from: https://grants.nih.gov/aboutoer/oer-offices/dbrw

Ref. 1062. National Institute of General Medical Sciences. Research Training. Accessed: March 31, 2026. Available from: https://www.nigms.nih.gov/research-training

Ref. 1063. Haque W, et al. (2026) JAMA Oncol, 12: 109. Available from: https://doi.org/10.1001/jamaoncol.2025.4985

Ref. 1064. STAT News. As political pressure mounts, medical school accreditor drops requirement to teach about health equity. Accessed: March 31, 2026. Available from: https://www.statnews.com/2026/03/27/medical-schools-dei-lcme-drops-structural-competency/

Ref. 1065. National Cancer Institute. Increasing Diversity in the Biomedical Workforce. Accessed: March 31, 2026. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2017/cure-workforce-diversity

Ref. 1066. American Society of Hematology. ASH Significantly Expands Bridge Grant Eligibility. Accessed: March 31, 2026. Available from: https://www.hematology.org/newsroom/press-releases/2025/ash-significantly-expands-bridge-grant-eligibility

Ref. 1067. US Department of Human and Health Services. Eliminating Tobacco-Related Disease and Death: Addressing Disparities—A Report of the Surgeon General. Accessed: March 31, 2026. Available from: https://www.hhs.gov/sites/default/files/2024-sgr-tobacco-related-health-disparities-full-report.pdf

Ref. 1068. American Heart Association. Report: Tobacco industry continuing decades-long targeting of Black communities, women, youth with menthol products. Accessed: March 31, 2026. Available from: https://newsroom.heart.org/news/report-tobacco-industry-continuing-decades-long-targeting-of-black-communities-women-youth-with-menthol-products

Ref. 1069. Centers for Disease Control and Prevention. African American Communities Experience a Health Burden From Commercial Tobacco. Accessed: March 31, 2026. Available from: https://www.cdc.gov/tobacco-health-equity/collection/african-american-health-burden.html

Ref. 1070. Wickham RJ (2020) Nicotine Tob Res, 22: 1676. Available from: https://doi.org/10.1093/ntr/ntz239

Ref. 1071. VanFrank B, et al. (2024) MMWR Morb Mortal Wkly Rep, 73: 633. Available from: https://doi.org/10.15585/mmwr.mm7329a1

Ref. 1072. NIH RePORTER. Reducing Cancer Disparities within the Black community in Jackson, MS through Community-Led Tobacco-Related Social Norm Change. Accessed: March 31, 2026. Available from: https://reporter.nih.gov/project-details/10456591

Ref. 1073. Patient-Centered Research Institute. Comparing Remotely Delivered Interventions To Promote Cessation Among Adults Who Smoke Menthol Cigarettes. Accessed: March 31, 2026. Available from: https://www.pcori.org/research-results/2025/remote-delivery-interventions-smoking-cessation

Ref. 1074. Han DH, et al. (2025) JAMA Netw Open, 8: e256739. Available from: https://doi.org/10.1001/jamanetworkopen.2025.6739

Ref. 1075. Xu L, et al. (2026) Int J Drug Policy, 150: 105178. Available from: https://doi.org/10.1016/j.drugpo.2026.105178

Ref. 1076. Mattingly DT, et al. (2026) Drug Alcohol Depend, 283: 113118. Available from: https://doi.org/10.1016/j.drugalcdep.2026.113118

Ref. 1077. Tobacco Free Kids. Denver Voters Uphold Law Ending Flavored Tobacco Sales in Big Win for Kids Over the Tobacco Industry. Accessed: March 31, 2026. Available from: https://www.tobaccofreekids.org/press-releases/2025_11_04_denver-voters-uphold-law-ending-flavored-tobacco-sales-in-big-win-for-kids-over-the-tobacco-industry

Ref. 1078. American Lung Association. State of Tobacco Control 2026. Accessed: March 31, 2026. Available from: https://www.lung.org/ca/state-of-tobacco-control/2026

Ref. 1079. US Environmental Protection Agency. Learn About Environmental Justice. Accessed: March 31, 2026. Available from: https://19january2021snapshot.epa.gov/environmentaljustice/learn-about-environmental-justice_.html

Ref. 1080. Lee EK, et al. (2022) Soc Sci Med, 294: 114696. Available from: https://doi.org/10.1016/j.socscimed.2021.114696

Ref. 1081. Egede LE, et al. (2023) Diabetes Care, 46: 667. Available from: https://doi.org/10.2337/dci22-0044

Ref. 1082. Zhang L, et al. (2023) JAMA Oncology, 9: 122. Available from: https://doi.org/10.1001/jamaoncol.2022.5382

Ref. 1083. RADONLEADERS.ORG. National Radon Action Plan. Accessed: March 31, 2026. Available from: https://radonleaders.org/resources/nationalradonactionplan

Ref. 1084. The White House. Ending Radical And Wasteful Government DEI Programs And Preferencing. Accessed: March 31, 2026. Available from: https://www.whitehouse.gov/presidential-actions/2025/01/ending-radical-and-wasteful-government-dei-programs-and-preferencing/

Ref. 1085. US Environmental Protection Agency. EPA Terminates Biden’s Environmental Justice, DEI Arms of Agency. Accessed: March 31, 2026. Available from: https://www.epa.gov/newsreleases/epa-terminates-bidens-environmental-justice-dei-arms-agency

Ref. 1086. US Environmental Protection Agency. Learn About Lead. Accessed: March 31, 2026. Available from: https://www.epa.gov/lead/learn-about-lead

Ref. 1087. US Environmental Protection Agency. Lead and Copper Rule Improvements. Accessed: March 31, 2026. Available from: https://www.epa.gov/ground-water-and-drinking-water/lead-and-copper-rule-improvements

Ref. 1088. Pradhan P, et al. (2025) JAMA Netw Open, 8: e2537905. Available from: https://doi.org/10.1001/jamanetworkopen.2025.37905

Ref. 1089. Potter AL, et al. (2024) J Thorac Cardiovasc Surg, 168: 248. Available from: https://doi.org/10.1016/j.jtcvs.2023.10.025

Ref. 1090. Lepe M (2024) Cancer Cytopathol, 132: 205. Available from: https://doi.org/10.1002/cncy.22752

Ref. 1091. Agenor M, et al. (2024) BMC Womens Health, 24: 362. Available from: https://doi.org/10.1186/s12905-024-03151-7

Ref. 1092. Mahmoud MA, et al. (2025) JAMA Netw Open, 8: e2525216. Available from: https://doi.org/10.1001/jamanetworkopen.2025.25216

Ref. 1093. Li CC, et al. (2024) J Natl Med Assoc, 116: 180. Available from: https://doi.org/10.1016/j.jnma.2024.01.008

Ref. 1094. Young CD, et al. (2025) JAMA Netw Open, 8: e252172. Available from: https://doi.org/10.1001/jamanetworkopen.2025.2172

Ref. 1095. Kobrin S, et al. (2026) Health Educ Behav, 53: 44. Available from: https://doi.org/10.1177/10901981251346803

Ref. 1096. Ferrari A, et al. (2025) Public Health Rev, 46: 1607873. Available from: https://doi.org/10.3389/phrs.2025.1607873

Ref. 1097. Taylor CD, et al. (2024) JAMA Health Forum, 5: e242814. Available from: https://doi.org/10.1001/jamahealthforum.2024.2814

Ref. 1098. May FP, et al. (2024) Contemp Clin Trials, 145: 107639. Available from: https://doi.org/10.1016/j.cct.2024.107639

Ref. 1099. Preston MA, et al. (2024) Cancer Med, 13: e7054. Available from: https://doi.org/10.1002/cam4.7054

Ref. 1100. Maceyko M, et al. (2026) JAMA Network Open, 9: e2554483. Available from: https://doi.org/10.1001/jamanetworkopen.2025.54483

Ref. 1101. Zhao J, et al. (2026) J Clin Oncol: Jco2501892. Available from: https://doi.org/10.1200/jco-25-01892

Ref. 1102. Bergstein A, et al. (2024) Gynecol Oncol, 189: 49. Available from: https://doi.org/10.1016/j.ygyno.2024.06.028

Ref. 1103. Shubeck SP, et al. (2026) JAMA Oncol, 12: 319. Available from: https://doi.org/10.1001/jamaoncol.2025.5774

Ref. 1104. Pratt R, et al. (2024) Prev Med Rep, 38: 102599. Available from: https://doi.org/10.1016/j.pmedr.2024.102599

Ref. 1105. Fokom Domgue J, et al. (2026) JAMA Netw Open, 9: e2558841. Available from: https://doi.org/10.1001/jamanetworkopen.2025.58841

Ref. 1106. The ASCO Post. FDA Approves At-Home Self-Collection Device for Cervical Cancer Screening. Accessed: March 31, 2026. Available from: https://ascopost.com/news/may-2025/fda-approves-at-home-self-collection-device-for-cervical-cancer-screening/

Ref. 1107. Health Resources and Services Administration. New Cervical Cancer Screening Guidelines Strengthen Women’s Preventive Health. Accessed: March 31, 2026. Available from: https://www.hrsa.gov/about/news/press-releases/new-cervical-cancer-screening-guidelines

Ref. 1108. United States Preventive Services Taskforce. Draft Recommendation: Cervical Cancer: Screening. Accessed: March 31, 2026. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/cervical-cancer-screening-adults-adolescents

Ref. 1109. Brodney S, et al. (2024) Cancer Med, 13: e70040. Available from: https://doi.org/10.1002/cam4.70040

Ref. 1110. Healthcare Administrative Partners. CT Colonography Receives National Coverage. Accessed: Available from: https://info.hapusa.com/blog-0/ct-colonography-receives-national-coverage

Ref. 1111. Kao SZ, et al. (2025) Cancer Med, 14: e71290. Available from: https://doi.org/10.1002/cam4.71290

Ref. 1112. United States Preventive Services Taskforce. Recommendation: Breast Cancer: Screening. Accessed: March 31, 2026. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening#bcei-recommendation-title-area

Ref. 1113. CNN. The task force that shapes Americans’ preventive care has not met in a year. Doctors now worry it’s being ‘abandoned’ by HHS. Accessed: March 31, 2026. Available from: https://www.cnn.com/2026/03/03/health/uspstf-preventive-care-hhs

Ref. 1114. US Congresswoman Terri Sewell. Rep. Sewell Celebrates House Passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Accessed: March 31, 2026. Available from: https://sewell.house.gov/2026/1/rep-sewell-celebrates-house-passage-of-the-nancy-gardner-sewell-medicare-multi-cancer-early-detection-screening-coverage-act

Ref. 1115. Congress.gov. Text – S.1866 – 119th Congress (2025-2026): SCREENS for Cancer Act of 2025. Accessed: Aprill 29, 2026. Available from: https://www.congress.gov/bill/119th-congress/senate-bill/1866/text

Ref. 1116. Congress.gov. H.R.4417 – Mobile Cancer Screening Act. Accessed: March 31, 2026. Available from: https://www.congress.gov/bill/119th-congress/house-bill/4752/text

Ref. 1117. National Cancer Institute. Division of Cancer Control and Population Sciences. Inherited Cancer Syndromes. Accessed: March 31, 2026. Available from: https://epi.grants.cancer.gov/inherited-cancer-syndromes/

Ref. 1118. Maria-Alexia P, et al. (2026) Cancer Genet, 302-303: 166. Available from: https://doi.org/10.1016/j.cancergen.2026.02.008

Ref. 1119. Duyar-Ayerdi S, et al. (2024) Obstet Gynecol Surv, 79: 673. Available from: https://doi.org/10.1097/OGX.0000000000001332

Ref. 1120. Congress.gov. Text – H.R.4752 – 119th Congress (2025-2026): Reducing Hereditary Cancer Act. Accessed: March 31, 2026. Available from: https://www.congress.gov/bill/119th-congress/house-bill/4752/text

Ref. 1121. Leader AE, et al. (2024) BMC Public Health, 24: 2533. Available from: https://doi.org/10.1186/s12889-024-20008-8

Ref. 1122. Rao ND, et al. (2024) Front Health Serv, 4: 1455365. Available from: https://doi.org/10.3389/frhs.2024.1455365

Ref. 1123. Rodriguez NJ, et al. (2023) Clin Gastroenterol Hepatol, 21: 3. Available from: https://doi.org/10.1016/j.cgh.2022.10.025

Ref. 1124. National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Committee on Women in Science, Engineering, and Medicine; Committee on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research; Bibbins-Domingo K, Helman A, editors. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. Washington (DC): National Academies Press (US); 2022 May 17. 2, Why Diverse Representation in Clinical Research Matters and the Current State of Representation within the Clinical Research Ecosystem. Available from: https://www.ncbi.nlm.nih.gov/books/NBK584396/

Ref. 1125. US Food & Drug Administration. Diversity Action Plans Summary FY 2023 and FY 2024. Accessed: March 31, 2026. Available from: https://www.fda.gov/media/184768/download

Ref. 1126. Ebrahimi H, et al. (2025) Am Soc Clin Oncol Educ Book, 45: e100052. Available from: https://doi.org/10.1200/EDBK-25-100052

Ref. 1127. US Food & Drug Administration. Enhancing Participation in Clinical Trials — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. Accessed: March 31, 2026. Available from: https://www.fda.gov/media/190162/download

Ref. 1128. Kammula AV, et al. (2024) Nat Commun, 15: 2608. Available from: https://doi.org/10.1038/s41467-024-46945-x

Ref. 1129. Franks JA, et al. (2023) J Natl Cancer Inst, 115: 530. Available from: https://doi.org/10.1093/jnci/djad031

Ref. 1130. Doshi SD, et al. (2024) Cancer J, 30: 8. Available from: https://doi.org/10.1097/PPO.0000000000000691

Ref. 1131. Office of the Assistant Secretary for Planning and Evaluation. Improving Access to Affordable and Equitable Health Coverage: A Review from 2010 to 2024. Accessed: March 31, 2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK611354/

Ref. 1132. American Medical Association. What to expect from the 2026 Medicare Physician Fee Schedule. Accessed: March 31, 2026. Available from: https://www.ama-assn.org/practice-management/medicare-medicaid/what-expect-2026-medicare-physician-fee-schedule

Ref. 1133. Centers for Medicare & Medicaid Services. Calendar Year (CY) 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F). Accessed: March 31, 2026. Available from: https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-medicare-physician-fee-schedule-final-rule-cms-1832-f

Ref. 1134. Lieberman DA, et al. (2025) Clin Gastroenterol Hepatol, 23: 1868. Available from: https://doi.org/10.1016/j.cgh.2025.05.023

Ref. 1135. Freeman HP (2006) J Urban Health, 83: 139. Available from: https://doi.org/10.1007/s11524-006-9030-0

Ref. 1136. Dwyer AJ, et al. (2022) Cancer, 128 Suppl 13: 2561. Available from: https://doi.org/10.1002/cncr.34162

Ref. 1137. Centers for Medicare & Medicaid Services. Calendar Year (CY) 2024 Medicare Physician Fee Schedule Final Rule. Accessed: March 31, 2026. Available from: https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2024-medicare-physician-fee-schedule-final-rule

Ref. 1138. Federal Register. Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Accessed: March 31, 2026. Available from: https://www.federalregister.gov/documents/2025/11/05/2025-19787/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other

Ref. 1139. American Cancer Society. Leadership in Oncology Navigation (LION™). Accessed: March 31, 2026. Available from: https://www.cancer.org/health-care-professionals/resources-for-professionals/patient-navigator-training.html

Ref. 1140. Dankwa-Mullan I, et al. (2025) Curr Oncol Rep, 27: 95. Available from: https://doi.org/10.1007/s11912-024-01627-1

Ref. 1141. Srivastav AK, et al. (2025) Cancers (Basel), 17. Available from: https://doi.org/10.3390/cancers17172866

Ref. 1142. Roadevin C, et al. (2025) J Med Ethics. Available from: https://doi.org/10.1136/jme-2025-110707

Ref. 1143. Kim S, et al. (2025) PLOS Digit Health, 4: e0001028. Available from: https://doi.org/10.1371/journal.pdig.0001028

Ref. 1144. Yang S, et al. (2025) J Med Internet Res, 27: e71349. Available from: https://doi.org/10.2196/71349

Ref. 1145. Hwang Y-M, et al. (2026) NEJM AI, 3: AIp2600103. Available from: https://doi.org/doi:10.1056/AIp2600103

Ref. 1146. The White House. Winning the Race America’s AI Action Plan. Accessed: March 31, 2026. Available from: https://www.whitehouse.gov/wp-content/uploads/2025/07/Americas-AI-Action-Plan.pdf

Ref. 1147. US Department of Human and Health Services. HHS Unveils AI Strategy to Transform Agency Operations. Accessed: 2026, Available from: https://www.hhs.gov/press-room/hhs-unveils-ai-strategy-to-transform-agency-operations.html

Ref. 1148. Office of the National Coordinator for Health Information Technology. HTI-1 Final Rule. Accessed: March 31, 2026. Available from: https://healthit.gov/regulations/hti-rules/hti-1-final-rule/

Ref. 1149. Congress.gov. H.R.5045 – 119th Congress (2025-2026): HEALTH AI Act. Accessed: March 31, 2026. Available from: https://www.congress.gov/bill/119th-congress/house-bill/5045

Ref. 1150. National Association for the Advancement of Colored People. Building a Healthier Future: Designing for AI Health Equity. Accessed: March 31, 2026. Available from: https://naacp.org/resources/building-healthier-future-designing-ai-health-equity

Ref. 1151. Kind AJH, et al. (2018) New England Journal of Medicine, 378: 2456. Available from: https://doi.org/doi:10.1056/NEJMp1802313

Ref. 1152. Flanagan BE, et al. (2018) J Environ Health, 80: 34. PMID: 32327766

Ref. 1153. Krieger N, et al. (2016) Am J Public Health, 106: 256. Available from: https://doi.org/10.2105/ajph.2015.302955

Ref. 1154. Agency for Toxic Substances and Disease Registry. EJI Technical Documentation | Place and Health – Geospatial Research, Analysis, and Services Program (GRASP). Accessed: Available from: https://www.atsdr.cdc.gov/place-health/php/eji/eji-technical-documentation.html